No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1x0sA, 1.0000, 0.00, 1.000, 227, 227, CRYSTAL STRUCTURE OF THE 13-CIS ISOMER OF BACTERIORHODOPSIN
2, 1iw6A, 0.9982, 0.23, 1.000, 227, 227, CRYSTAL STRUCTURE OF THE GROUND STATE OF BACTERIORHODOPSIN
3, 1ixfA, 0.9981, 0.24, 1.000, 227, 227, CRYSTAL STRUCTURE OF THE K INTERMEDIATE OF BACTERIORHODOPSIN
4, 2zfeA, 0.9977, 0.27, 1.000, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN-XENON COMPLEX
5, 1ucqA, 0.9977, 0.27, 1.000, 227, 227, CRYSTAL STRUCTURE OF THE L INTERMEDIATE OF BACTERIORHODOPSIN
6, 1x0k1, 0.9966, 0.33, 1.000, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN AT PH 10
7, 1iw9A, 0.9953, 0.38, 1.000, 227, 227, CRYSTAL STRUCTURE OF THE M INTERMEDIATE OF BACTERIORHODOPSIN
8, 2zzlA, 0.9951, 0.39, 1.000, 228, 227, STRUCTURE OF BACTERIORHODOPSIN S M INTERMEDIATE AT PH 7
9, 1vjmA, 0.9928, 0.49, 1.000, 228, 227, DEFORMATION OF HELIX C IN THE LOW-TEMPERATURE L-INTERMEDIATE OF BACTERIORHODOPSIN
10, 1qhjA, 0.9928, 0.49, 1.000, 228, 227, X-RAY STRUCTURE OF BACTERIORHODOPSIN GROWN IN LIPIDIC CUBIC PHASES
11, 1qkpA, 0.9926, 0.49, 1.000, 228, 227, HIGH RESOLUTION X-RAY STRUCTURE OF AN EARLY INTERMEDIATE IN THE BACTERIORHODOPSIN PHOTOCYCLE
12, 1qkoA, 0.9925, 0.49, 1.000, 228, 227, HIGH RESOLUTION X-RAY STRUCTURE OF AN EARLY INTERMEDIATE IN THE BACTERIORHODOPSIN PHOTOCYCLE
13, 1qm8A, 0.9924, 0.32, 1.000, 229, 226, STRUCTURE OF BACTERIORHODOPSIN AT 100 K
14, 1brrC, 0.9910, 0.59, 1.000, 231, 227, X-RAY STRUCTURE OF THE BACTERIORHODOPSIN TRIMER/LIPID COMPLEX
15, 3vi0A, 0.9908, 0.90, 0.996, 227, 227, CRYSTAL STRUCTURE OF THE O INTERMEDIATE OF THE L93A MUTANT OF BACTERIORHODOPSIN
16, 3vhzA, 0.9906, 0.50, 0.996, 228, 226, CRYSTAL STRUCTURE OF THE TRANS ISOMER OF THE L93A MUTANT OF BACTERIORHODOPSIN
17, 1brrA, 0.9893, 0.64, 1.000, 230, 227, X-RAY STRUCTURE OF THE BACTERIORHODOPSIN TRIMER/LIPID COMPLEX
18, 1brrB, 0.9889, 0.65, 1.000, 231, 227, X-RAY STRUCTURE OF THE BACTERIORHODOPSIN TRIMER/LIPID COMPLEX
19, 1r84A, 0.9888, 0.65, 1.000, 232, 227, NMR STRUCTURE OF THE 13-CIS-15-SYN RETINAL IN DARK_ADAPTED BACTERIORHODOPSIN
20, 1r2nA, 0.9887, 0.65, 1.000, 232, 227, NMR STRUCTURE OF THE ALL-TRANS RETINAL IN DARK-ADAPTED BACTERIORHODOPSIN
21, 6g7hA, 0.9878, 0.95, 1.000, 230, 227, RETINAL ISOMERIZATION IN BACTERIORHODOPSIN REVEALED BY A FEMTOSECOND X-RAY LASER: RESTING STATE STRUCTURE 
22, 6g7iA, 0.9876, 0.97, 1.000, 230, 227, RETINAL ISOMERIZATION IN BACTERIORHODOPSIN REVEALED BY A FEMTOSECOND X-RAY LASER: 49-406 FS STATE STRUCTURE 
23, 1e0pA, 0.9875, 0.64, 1.000, 228, 227, L INTERMEDIATE OF BACTERIORHODOPSIN
24, 5h2pA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 657 US AFTER PHOTOEXCITATION
25, 5h2oA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 250 US AFTER PHOTOEXCITATION
26, 5h2nA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 95.2 US AFTER PHOTOEXCITATION
27, 5h2mA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 13.8 US AFTER PHOTOEXCITATION
28, 5h2lA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 5.25 US AFTER PHOTOEXCITATION
29, 5h2kA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 2 US AFTER PHOTOEXCITATION
30, 5h2jA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 290 NS AFTER PHOTOEXCITATION
31, 5h2iA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 110 NS AFTER PHOTOEXCITATION
32, 5h2hA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 40 NS AFTER PHOTOEXCITATION
33, 5b6zA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 1.725 MS US AFTER PHOTOEXCITATION
34, 5b6yA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 36.2 US AFTER PHOTOEXCITATION
35, 5b6xA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 760 NS AFTER PHOTOEXCITATION
36, 5b6wA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: STRUCTURE OBTAINED 16 NS AFTER PHOTOEXCITATION
37, 5b6vA, 0.9871, 0.95, 0.996, 231, 227, A THREE DIMENSIONAL MOVIE OF STRUCTURAL CHANGES IN BACTERIORHODOPSIN: RESTING STATE STRUCTURE
38, 6g7kA, 0.9870, 0.96, 1.000, 230, 227, RETINAL ISOMERIZATION IN BACTERIORHODOPSIN REVEALED BY A FEMTOSECOND X-RAY LASER: 10 PS STATE STRUCTURE 
39, 4hwlB, 0.9869, 0.88, 1.000, 227, 227, CRYSTAL STRUCTURE ANALYSIS OF THE BACTERIORHODOPSIN IN FACIAL AMPHIPHILE-7 DMPC BICELLE
40, 4hwlA, 0.9867, 0.89, 1.000, 227, 227, CRYSTAL STRUCTURE ANALYSIS OF THE BACTERIORHODOPSIN IN FACIAL AMPHIPHILE-7 DMPC BICELLE
41, 1kmeB, 0.9866, 0.90, 1.000, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN CRYSTALLIZED FROM BICELLES
42, 1kmeA, 0.9866, 0.90, 1.000, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN CRYSTALLIZED FROM BICELLES
43, 1dzeA, 0.9865, 0.39, 1.000, 225, 225, STRUCTURE OF THE M INTERMEDIATE OF BACTERIORHODOPSIN TRAPPED AT 100K
44, 1q5jA, 0.9864, 0.88, 0.996, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT P91A CRYSTALLIZED FROM BICELLES
45, 3codB, 0.9863, 0.88, 0.991, 227, 227, CRYSTAL STRUCTURE OF T90A/D115A MUTANT OF BACTERIORHODOPSIN
46, 3codA, 0.9863, 0.88, 0.991, 227, 227, CRYSTAL STRUCTURE OF T90A/D115A MUTANT OF BACTERIORHODOPSIN
47, 1s54B, 0.9863, 0.88, 0.996, 227, 227, THR24ALA BACTERIORHODOPSIN
48, 1s54A, 0.9863, 0.88, 0.996, 227, 227, THR24ALA BACTERIORHODOPSIN
49, 1q5jB, 0.9863, 0.89, 0.996, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT P91A CRYSTALLIZED FROM BICELLES
50, 1py6B, 0.9863, 0.88, 1.000, 227, 227, BACTERIORHODOPSIN CRYSTALLIZED FROM BICELLS
51, 1py6A, 0.9863, 0.88, 1.000, 227, 227, BACTERIORHODOPSIN CRYSTALLIZED FROM BICELLS
52, 3utxA, 0.9862, 0.89, 0.996, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT T46A
53, 1s53B, 0.9860, 0.90, 0.996, 227, 227, THR46SER BACTERIORHODOPSIN
54, 1s53A, 0.9860, 0.90, 0.996, 227, 227, THR46SER BACTERIORHODOPSIN
55, 1pxsB, 0.9860, 0.90, 0.996, 227, 227, STRUCTURE OF MET56ALA MUTANT OF BACTERIORHODOPSIN
56, 1pxsA, 0.9860, 0.90, 0.996, 227, 227, STRUCTURE OF MET56ALA MUTANT OF BACTERIORHODOPSIN
57, 3cocB, 0.9859, 0.90, 0.996, 227, 227, CRYSTAL STRUCTURE OF D115A MUTANT OF BACTERIORHODOPSIN
58, 3cocA, 0.9859, 0.90, 0.996, 227, 227, CRYSTAL STRUCTURE OF D115A MUTANT OF BACTERIORHODOPSIN
59, 1s51B, 0.9858, 0.90, 0.996, 227, 227, THR24SER BACTERIORHODOPSIN
60, 1s51A, 0.9858, 0.90, 0.996, 227, 227, THR24SER BACTERIORHODOPSIN
61, 3utxB, 0.9857, 0.90, 0.996, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT T46A
62, 1s52A, 0.9856, 0.91, 0.996, 227, 227, THR24VAL BACTERIORHODOPSIN
63, 4y9hA, 0.9855, 0.65, 1.000, 226, 226, THE 1.43 ANGSTROM CRYSTAL STRUCTURE OF BACTERIORHODOPSIN CRYSTALLIZED FROM BICELLES
64, 1s52B, 0.9855, 0.91, 0.996, 227, 227, THR24VAL BACTERIORHODOPSIN
65, 1q5iA, 0.9855, 0.91, 0.996, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT P186A CRYSTALLIZED FROM BICELLES
66, 3hasA, 0.9854, 0.65, 0.996, 226, 226, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT L152A CRYSTALLIZED FROM BICELLES
67, 1q5iB, 0.9854, 0.91, 0.996, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT P186A CRYSTALLIZED FROM BICELLES
68, 3harA, 0.9853, 0.65, 0.996, 226, 226, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT I148V CRYSTALLIZED FROM BICELLES
69, 3haoA, 0.9853, 0.66, 0.996, 226, 226, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT L94A CRYSTALLIZED FROM BICELLES
70, 3t45C, 0.9852, 0.44, 0.996, 225, 225, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT A215T A PHOTOTAXIS SIGNALING MUTANT AT 3.0 A RESOLUTION
71, 4hyxA, 0.9851, 0.67, 1.000, 226, 226, CRYSTAL STRUCTURE ANALYSIS OF THE BACTERIORHODOPSIN IN FACIAL AMPHIPHILE-4 DMPC BICELLE
72, 3t45B, 0.9851, 0.44, 0.996, 225, 225, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT A215T A PHOTOTAXIS SIGNALING MUTANT AT 3.0 A RESOLUTION
73, 3t45A, 0.9851, 0.44, 0.996, 225, 225, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT A215T A PHOTOTAXIS SIGNALING MUTANT AT 3.0 A RESOLUTION
74, 6g7jA, 0.9850, 1.02, 1.000, 230, 227, RETINAL ISOMERIZATION IN BACTERIORHODOPSIN REVEALED BY A FEMTOSECOND X-RAY LASER: 457-646 FS STATE STRUCTURE 
75, 3utwA, 0.9850, 0.87, 0.991, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT P50A/Y57F
76, 3hapA, 0.9850, 0.66, 0.996, 226, 226, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT L111A CRYSTALLIZED FROM BICELLES
77, 3haqA, 0.9849, 0.66, 0.996, 226, 226, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT I148A CRYSTALLIZED FROM BICELLES
78, 1pxrB, 0.9849, 0.67, 0.996, 226, 226, STRUCTURE OF PRO50ALA MUTANT OF BACTERIORHODOPSIN
79, 1pxrA, 0.9849, 0.67, 0.996, 226, 226, STRUCTURE OF PRO50ALA MUTANT OF BACTERIORHODOPSIN
80, 3haoB, 0.9848, 0.67, 0.996, 226, 226, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT L94A CRYSTALLIZED FROM BICELLES
81, 1tn0A, 0.9848, 0.92, 0.996, 227, 227, STRUCTURE OF BACTERORHODOPSIN MUTANT A51P
82, 1tn0B, 0.9847, 0.92, 0.996, 227, 227, STRUCTURE OF BACTERORHODOPSIN MUTANT A51P
83, 1tn5B, 0.9844, 0.92, 0.996, 227, 227, STRUCTURE OF BACTERORHODOPSIN MUTANT K41P
84, 1tn5A, 0.9844, 0.92, 0.996, 227, 227, STRUCTURE OF BACTERORHODOPSIN MUTANT K41P
85, 6g7lA, 0.9843, 1.00, 1.000, 230, 227, RETINAL ISOMERIZATION IN BACTERIORHODOPSIN REVEALED BY A FEMTOSECOND X-RAY LASER: 8.3 MS STATE STRUCTURE 
86, 4xxjA, 0.9843, 0.95, 1.000, 228, 226, CRYSTAL STRUCTURE OF ESCHERICHIA COLI-EXPRESSED HALOBACTERIUM SALINARUM BACTERIORHODOPSIN IN THE TRIMERIC FORM
87, 4x31A, 0.9838, 1.04, 1.000, 229, 227, ROOM TEMPERATURE STRUCTURE OF BACTERIORHODOPSIN FROM LIPIDIC CUBIC PHASE OBTAINED WITH SERIAL MILLISECOND CRYSTALLOGRAPHY USING SYNCHROTRON RADIATION
88, 3utyA, 0.9828, 0.95, 0.991, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT P50A/T46A
89, 4hyxB, 0.9826, 0.84, 0.996, 231, 226, CRYSTAL STRUCTURE ANALYSIS OF THE BACTERIORHODOPSIN IN FACIAL AMPHIPHILE-4 DMPC BICELLE
90, 4xxjC, 0.9821, 0.64, 1.000, 227, 225, CRYSTAL STRUCTURE OF ESCHERICHIA COLI-EXPRESSED HALOBACTERIUM SALINARUM BACTERIORHODOPSIN IN THE TRIMERIC FORM
91, 5vn9B, 0.9820, 0.62, 1.000, 225, 225, STRUCTURE OF BACTERIORHODOPSIN FROM CRYSTALS GROWN AT 4 DEG C USING GLYNCOC15+4 AS AN LCP HOST LIPID
92, 3utvA, 0.9819, 0.74, 0.996, 227, 226, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT Y57F
93, 3utyB, 0.9808, 1.00, 0.991, 227, 227, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT P50A/T46A
94, 1xjiA, 0.9808, 0.66, 1.000, 225, 225, BACTERIORHODOPSIN CRYSTALLIZED IN BICELLES AT ROOM TEMPERATURE
95, 5b35A, 0.9806, 0.65, 1.000, 225, 225, SERIAL FEMTOSECOND CRYSTALLOGRAPHY (SFX) OF GROUND STATE BACTERIORHODOPSIN CRYSTALLIZED FROM BICELLES DETERMINED USING 7-KEV X-RAY FREE ELECTRON LASER (XFEL) AT SACLA
96, 4fbzA, 0.9801, 0.87, 0.546, 238, 227, CRYSTAL STRUCTURE OF DELTARHODOPSIN FROM HALOTERRIGENA THERMOTOLERANS
97, 3hanA, 0.9801, 0.68, 0.996, 225, 225, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN MUTANT V49A CRYSTALLIZED FROM BICELLES
98, 5vn9A, 0.9797, 0.67, 1.000, 225, 225, STRUCTURE OF BACTERIORHODOPSIN FROM CRYSTALS GROWN AT 4 DEG C USING GLYNCOC15+4 AS AN LCP HOST LIPID
99, 5vn7A, 0.9791, 0.61, 1.000, 224, 224, STRUCTURE OF BACTERIORHODOPSIN FROM CRYSTALS GROWN AT 20 DEG CELCIUS USING GLYNCOC15+4 AS AN LCP HOST LIPID
100, 2z55A, 0.9790, 1.03, 0.564, 242, 227, BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2
101, 2z55D, 0.9784, 1.02, 0.568, 237, 227, BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2
102, 2z55B, 0.9784, 1.02, 0.568, 238, 227, BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2
103, 5b34A, 0.9783, 0.53, 1.000, 224, 224, SERIAL FEMTOSECOND CRYSTALLOGRAPHY (SFX) OF GROUND STATE BACTERIORHODOPSIN CRYSTALLIZED FROM BICELLES IN COMPLEX WITH IODINE- LABELED DETERGENT HAD13A DETERMINED USING 7-KEV X-RAY FREE ELECTRON LASER (XFEL) AT SACLA
104, 2ei4A, 0.9779, 1.04, 0.568, 238, 227, TRIMERIC COMPLEX OF ARCHAERHODOPSIN-2
105, 2z55E, 0.9762, 1.07, 0.564, 238, 227, BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2
106, 5j7aA, 0.9744, 0.95, 1.000, 224, 224, BACTERIORHODOPSIN GROUND STATE STRUCTURE OBTAINED WITH SERIAL FEMTOSECOND CRYSTALLOGRAPHY
107, 1uazB, 0.9722, 1.04, 0.597, 236, 226, CRYSTAL STRUCTURE OF ARCHAERHODOPSIN-1
108, 1uazA, 0.9720, 1.04, 0.597, 236, 226, CRYSTAL STRUCTURE OF ARCHAERHODOPSIN-1
109, 3wqjA, 0.9715, 0.97, 0.569, 234, 225, CRYSTAL STRUCTURE OF ARCHAERHODOPSIN-2 AT 1.8 ANGSTROM RESOLUTION
110, 5itcB, 0.9714, 0.95, 0.558, 228, 226, 2.2-ANGSTROM IN MESO CRYSTAL STRUCTURE OF HALOQUADRATUM WALSBYI BACTERIORHODOPSIN (HWBR) FROM STYRENE MALEIC ACID (SMA) POLYMER NANODISCS
111, 1at9A, 0.9710, 1.33, 1.000, 230, 227, STRUCTURE OF BACTERIORHODOPSIN AT 3.0 ANGSTROM DETERMINED BY ELECTRON CRYSTALLOGRAPHY
112, 5itcA, 0.9709, 0.97, 0.558, 228, 226, 2.2-ANGSTROM IN MESO CRYSTAL STRUCTURE OF HALOQUADRATUM WALSBYI BACTERIORHODOPSIN (HWBR) FROM STYRENE MALEIC ACID (SMA) POLYMER NANODISCS
113, 5iteA, 0.9705, 0.98, 0.558, 228, 226, 2.2-ANGSTROM IN MESO CRYSTAL STRUCTURE OF HALOQUADRATUM WALSBYI BACTERIORHODOPSIN (HWBR) FROM OCTYLGLUCOSIDE (OG) DETERGENT MICELLES
114, 5itcC, 0.9705, 0.98, 0.558, 228, 226, 2.2-ANGSTROM IN MESO CRYSTAL STRUCTURE OF HALOQUADRATUM WALSBYI BACTERIORHODOPSIN (HWBR) FROM STYRENE MALEIC ACID (SMA) POLYMER NANODISCS
115, 1fbbA, 0.9704, 0.62, 1.000, 224, 223, CRYSTAL STRUCTURE OF NATIVE CONFORMATION OF BACTERIORHODOPSIN
116, 5iteC, 0.9703, 0.98, 0.558, 228, 226, 2.2-ANGSTROM IN MESO CRYSTAL STRUCTURE OF HALOQUADRATUM WALSBYI BACTERIORHODOPSIN (HWBR) FROM OCTYLGLUCOSIDE (OG) DETERGENT MICELLES
117, 5iteB, 0.9703, 0.98, 0.558, 228, 226, 2.2-ANGSTROM IN MESO CRYSTAL STRUCTURE OF HALOQUADRATUM WALSBYI BACTERIORHODOPSIN (HWBR) FROM OCTYLGLUCOSIDE (OG) DETERGENT MICELLES
118, 5kkhB, 0.9700, 0.99, 0.558, 228, 226, 2.1-ANGSTROM IN SITU MYLAR STRUCTURE OF BACTERIORHODOPSIN FROM HALOQUADRATUM WALSBYI (HWBR) AT 100 K
119, 5kkhC, 0.9699, 0.99, 0.558, 228, 226, 2.1-ANGSTROM IN SITU MYLAR STRUCTURE OF BACTERIORHODOPSIN FROM HALOQUADRATUM WALSBYI (HWBR) AT 100 K
120, 5kkhA, 0.9698, 0.98, 0.558, 228, 226, 2.1-ANGSTROM IN SITU MYLAR STRUCTURE OF BACTERIORHODOPSIN FROM HALOQUADRATUM WALSBYI (HWBR) AT 100 K
121, 4qidA, 0.9698, 1.08, 0.559, 228, 227, CRYSTAL STRUCTURE OF HALOQUADRATUM WALSBYI BACTERIORHODOPSIN
122, 4qi1C, 0.9694, 1.00, 0.558, 228, 226, CRYSTAL STRUCTURE OF H. WALSBYI BACTERIORHODOPSIN
123, 4qi1A, 0.9693, 1.00, 0.558, 228, 226, CRYSTAL STRUCTURE OF H. WALSBYI BACTERIORHODOPSIN
124, 4qi1B, 0.9692, 1.00, 0.558, 228, 226, CRYSTAL STRUCTURE OF H. WALSBYI BACTERIORHODOPSIN
125, 4pxkA, 0.9692, 1.11, 0.546, 236, 227, CRYSTAL STRUCTURE OF HALOARCULA MARISMORTUI BACTERIORHODOPSIN I D94N MUTANT
126, 4jr8A, 0.9690, 1.00, 0.553, 234, 226, CRYSTAL STRUCTURE OF CRUXRHODOPSIN-3 FROM HALOARCULA VALLISMORTIS AT 2.3 ANGSTROM RESOLUTION
127, 1cwqA, 0.9687, 1.26, 0.969, 238, 226, M INTERMEDIATE STRUCTURE OF THE WILD TYPE BACTERIORHODOPSIN IN COMBINATION WITH THE GROUND STATE STRUCTURE
128, 3nsbA, 0.9684, 0.82, 1.000, 223, 223, STRUCTURE OF BACTERIORHODOPSIN GROUND STATE BEFORE AND AFTER X-RAY MODIFICATION
129, 3ns0A, 0.9684, 0.82, 1.000, 223, 223, X-RAY STRUCTURE OF BACTERIORHODOPSIN
130, 4l35A, 0.9682, 1.12, 0.546, 244, 227, CRYSTAL STRUCTURE OF CRUXRHODOPSIN-3 AT PH5 FROM HALOARCULA VALLISMORTIS AT 2.1 ANGSTROM RESOLUTION
131, 1m0lA, 0.9654, 0.95, 1.000, 222, 222, BACTERIORHODOPSIN/LIPID COMPLEX AT 1.47 A RESOLUTION
132, 1m0kA, 0.9652, 0.97, 1.000, 222, 222, BACTERIORHODOPSIN K INTERMEDIATE AT 1.43 A RESOLUTION
133, 1p8iA, 0.9646, 0.97, 0.995, 222, 222, F219L BACTERIORHODOPSIN MUTANT
134, 2ntuA, 0.9643, 0.97, 1.000, 222, 222, BACTERIORHODOPSIN WILD TYPE BEFORE ILLUMINATION
135, 1vgoA, 0.9643, 1.25, 0.568, 233, 227, CRYSTAL STRUCTURE OF ARCHAERHODOPSIN-2
136, 2i21A, 0.9642, 0.96, 0.995, 222, 222, BACTERIORHODOPSIN/LIPID COMPLEX T46V MUTANT
137, 2ntwA, 0.9641, 0.96, 1.000, 222, 222, BACTERIORHODOPSIN WILD TYPE AFTER ILLUMINATION TO PRODUCE THE L INTERMEDIATE
138, 1kgbA, 0.9641, 0.99, 1.000, 222, 222, STRUCTURE OF GROUND-STATE BACTERIORHODOPSIN
139, 3mbvA, 0.9638, 1.01, 1.000, 222, 222, STRUCTURE OF BACTERIRHODOPSIN CRYSTALLIZED IN BETTA-XYLOC(16+4) MESO PHASE
140, 1m0mA, 0.9633, 0.99, 1.000, 222, 222, BACTERIORHODOPSIN M1 INTERMEDIATE AT 1.43 A RESOLUTION
141, 2i1xA, 0.9631, 0.99, 0.995, 222, 222, BACTERIORHODOPSIN/LIPID COMPLEX D96A MUTANT
142, 1c3wA, 0.9630, 0.99, 1.000, 222, 222, BACTERIORHODOPSIN/LIPID COMPLEX AT 1.55 A RESOLUTION
143, 1o0aA, 0.9626, 1.02, 1.000, 222, 222, BACTERIORHODOPSIN L INTERMEDIATE AT 1.62 A RESOLUTION
144, 2wjlA, 0.9623, 1.02, 0.995, 222, 222, BACTERIORHODOPSIN MUTANT E194D
145, 1p8hA, 0.9623, 1.02, 1.000, 222, 222, BACTERIORHODOPSIN M1 INTERMEDIATE PRODUCED AT ROOM TEMPERATURE
146, 1f4zA, 0.9621, 1.00, 0.995, 222, 222, BACTERIORHODOPSIN-M PHOTOINTERMEDIATE STATE OF THE E204Q MUTANT AT 1.8 ANGSTROM RESOLUTION
147, 1c8rA, 0.9619, 1.04, 0.995, 222, 222, BACTERIORHODOPSIN D96N BR STATE AT 2.0 A RESOLUTION
148, 4wavA, 0.9618, 1.14, 0.553, 227, 226, CRYSTAL STRUCTURE OF HALOQUADRATUM WALSBYI BACTERIORHODOPSIN MUTANT D93N
149, 1f50A, 0.9614, 1.01, 0.995, 222, 222, BACTERIORHODOPSIN-BR STATE OF THE E204Q MUTANT AT 1.7 ANGSTROM RESOLUTION
150, 4xxjB, 0.9613, 0.98, 0.995, 223, 221, CRYSTAL STRUCTURE OF ESCHERICHIA COLI-EXPRESSED HALOBACTERIUM SALINARUM BACTERIORHODOPSIN IN THE TRIMERIC FORM
151, 1bm1A, 0.9605, 0.68, 0.991, 221, 221, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN IN THE LIGHT-ADAPTED STATE
152, 4md2A, 0.9604, 0.97, 1.000, 224, 221, GROUND STATE OF BACTERIORHODOPSIN FROM HALOBACTERIUM SALINARUM
153, 4md1A, 0.9604, 0.97, 1.000, 224, 221, ORANGE SPECIES OF BACTERIORHODOPSIN FROM HALOBACTERIUM SALINARUM
154, 2i20A, 0.9603, 1.02, 0.995, 222, 222, BACTERIORHODOPSIN/LIPID COMPLEX M STATE OF D96A MUTANT
155, 1kg9A, 0.9602, 0.96, 1.000, 221, 221, STRUCTURE OF A MOCK-TRAPPED EARLY-M INTERMEDIATE OF BACTERIORHOSOPSIN
156, 1fbkA, 0.9588, 1.00, 0.969, 225, 224, CRYSTAL STRUCTURE OF CYTOPLASMICALLY OPEN CONFORMATION OF BACTERIORHODOPSIN
157, 1vgoB, 0.9568, 1.34, 0.568, 235, 227, CRYSTAL STRUCTURE OF ARCHAERHODOPSIN-2
158, 4x32A, 0.9567, 1.06, 0.986, 222, 221, BACTERIORHODOPSIN GROUND STATE STRUCTURE COLLECTED IN CRYO CONDITIONS FROM CRYSTALS OBTAINED IN LCP WITH PEG AS A PRECIPITANT.
159, 5br5A, 0.9564, 0.97, 0.995, 222, 220, STRUCTURE OF BACTERIORHODOPSIN CRYSTALLIZED FROM ND-MSP1E3D1
160, 1cwqB, 0.9563, 1.31, 0.982, 238, 226, M INTERMEDIATE STRUCTURE OF THE WILD TYPE BACTERIORHODOPSIN IN COMBINATION WITH THE GROUND STATE STRUCTURE
161, 1p8uA, 0.9557, 1.13, 0.995, 222, 222, BACTERIORHODOPSIN N  INTERMEDIATE AT 1.62 A RESOLUTION
162, 5vn7B, 0.9534, 1.54, 1.000, 228, 224, STRUCTURE OF BACTERIORHODOPSIN FROM CRYSTALS GROWN AT 20 DEG CELCIUS USING GLYNCOC15+4 AS AN LCP HOST LIPID
163, 4qidB, 0.9526, 1.03, 0.565, 224, 223, CRYSTAL STRUCTURE OF HALOQUADRATUM WALSBYI BACTERIORHODOPSIN
164, 4wavB, 0.9500, 1.18, 0.554, 226, 224, CRYSTAL STRUCTURE OF HALOQUADRATUM WALSBYI BACTERIORHODOPSIN MUTANT D93N
165, 5a45A, 0.9481, 0.61, 1.000, 217, 217, STRUCTURE OF BACTERIORHODOPSIN OBTAINED FROM 5UM CRYSTALS BY MULTI CRYSTAL DATA COLLECTION
166, 3a7kB, 0.9441, 1.36, 0.311, 258, 225, CRYSTAL STRUCTURE OF HALORHODOPSIN FROM NATRONOMONAS PHARAONIS
167, 3qbiB, 0.9437, 1.36, 0.311, 260, 225, CRYSTAL STRUCTURE OF AN ANION-FREE YELLOW FORM OF PHARAONIS HALORHODOPSIN
168, 3qbkD, 0.9435, 1.37, 0.311, 259, 225, BROMIDE-BOUND FORM OF PHARAONIS HALORHODOPSIN
169, 3abwD, 0.9433, 1.37, 0.311, 259, 225, CRYSTAL STRUCTURE OF PHARAONIS HALORHODOPSIN IN COMPLEX WITH AZIDE ION
170, 3a7kD, 0.9433, 1.38, 0.311, 259, 225, CRYSTAL STRUCTURE OF HALORHODOPSIN FROM NATRONOMONAS PHARAONIS
171, 3qblB, 0.9432, 1.37, 0.311, 259, 225, PHARAONIS HALORHODOPSIN COMPLEXED WITH NITRATE
172, 3qbkB, 0.9432, 1.37, 0.311, 259, 225, BROMIDE-BOUND FORM OF PHARAONIS HALORHODOPSIN
173, 3abwB, 0.9432, 1.37, 0.311, 259, 225, CRYSTAL STRUCTURE OF PHARAONIS HALORHODOPSIN IN COMPLEX WITH AZIDE ION
174, 3qblD, 0.9430, 1.38, 0.311, 259, 225, PHARAONIS HALORHODOPSIN COMPLEXED WITH NITRATE
175, 5etzB, 0.9425, 1.38, 0.311, 260, 225, STRUCTURE OF THE ALL-TRANS ISOMER OF PHARAONIS HALORHODOPSIN IN THE ABSENCE OF HALIDE IONS
176, 5br2A, 0.9423, 0.66, 1.000, 216, 216, STRUCTURE OF BACTERIORHODOPSIN CRYSTALLIZED FROM ND-MSP1
177, 3qbgB, 0.9420, 1.39, 0.311, 260, 225, ANION-FREE BLUE FORM OF PHARAONIS HALORHODOPSIN
178, 3qblA, 0.9419, 1.38, 0.311, 260, 225, PHARAONIS HALORHODOPSIN COMPLEXED WITH NITRATE
179, 3a7kA, 0.9418, 1.39, 0.311, 259, 225, CRYSTAL STRUCTURE OF HALORHODOPSIN FROM NATRONOMONAS PHARAONIS
180, 3qbiD, 0.9417, 1.40, 0.316, 260, 225, CRYSTAL STRUCTURE OF AN ANION-FREE YELLOW FORM OF PHARAONIS HALORHODOPSIN
181, 3qbkA, 0.9415, 1.40, 0.311, 261, 225, BROMIDE-BOUND FORM OF PHARAONIS HALORHODOPSIN
182, 3abwA, 0.9414, 1.40, 0.311, 260, 225, CRYSTAL STRUCTURE OF PHARAONIS HALORHODOPSIN IN COMPLEX WITH AZIDE ION
183, 2at9A, 0.9411, 1.23, 0.977, 222, 221, STRUCTURE OF BACTERIORHODOPSIN AT 3.0 ANGSTROM BY ELECTRON CRYSTALLOGRAPHY
184, 3qbgD, 0.9410, 1.41, 0.316, 260, 225, ANION-FREE BLUE FORM OF PHARAONIS HALORHODOPSIN
185, 5etzD, 0.9409, 1.41, 0.311, 260, 225, STRUCTURE OF THE ALL-TRANS ISOMER OF PHARAONIS HALORHODOPSIN IN THE ABSENCE OF HALIDE IONS
186, 3qbiA, 0.9400, 1.42, 0.316, 261, 225, CRYSTAL STRUCTURE OF AN ANION-FREE YELLOW FORM OF PHARAONIS HALORHODOPSIN
187, 3vvkC, 0.9395, 1.43, 0.316, 259, 225, AN M-LIKE REACTION STATE OF THE AZIDE-BOUND PURPLE FORM OF PHARAONIS HALORHODOPSIN
188, 5etzA, 0.9394, 1.43, 0.316, 261, 225, STRUCTURE OF THE ALL-TRANS ISOMER OF PHARAONIS HALORHODOPSIN IN THE ABSENCE OF HALIDE IONS
189, 3vvkA, 0.9394, 1.43, 0.307, 261, 225, AN M-LIKE REACTION STATE OF THE AZIDE-BOUND PURPLE FORM OF PHARAONIS HALORHODOPSIN
190, 3qbgA, 0.9392, 1.43, 0.316, 261, 225, ANION-FREE BLUE FORM OF PHARAONIS HALORHODOPSIN
191, 4qryA, 0.9388, 1.44, 0.311, 261, 225, THE GROUND STATE AND THE N INTERMEDIATE OF PHARAONIS HALORHODOPSIN IN COMPLEX WITH BROMIDE ION
192, 5b0wB, 0.9385, 1.43, 0.316, 260, 225, CRYSTAL STRUCTURE OF THE 11-CIS ISOMER OF PHARAONIS HALORHODOPSIN IN THE ABSENCE OF HALIDE IONS
193, 5b0wA, 0.9382, 1.44, 0.311, 261, 225, CRYSTAL STRUCTURE OF THE 11-CIS ISOMER OF PHARAONIS HALORHODOPSIN IN THE ABSENCE OF HALIDE IONS
194, 4fpdA, 0.9379, 1.83, 0.987, 225, 225, DEPROTONATION OF D96 IN BACTERIORHODOPSIN OPENS THE PROTON UPTAKE PATHWAY
195, 1kg8A, 0.9368, 1.01, 1.000, 216, 216, X-RAY STRUCTURE OF AN EARLY-M INTERMEDIATE OF BACTERIORHODOPSIN
196, 5b0wD, 0.9366, 1.47, 0.311, 259, 225, CRYSTAL STRUCTURE OF THE 11-CIS ISOMER OF PHARAONIS HALORHODOPSIN IN THE ABSENCE OF HALIDE IONS
197, 5ahyA, 0.9363, 1.55, 0.333, 242, 225, HALORHODOPSIN FROM HALOBACTERIUM SALINARUM IN A NEW RHOMBOHEDRAL CRYSTAL FORM
198, 4ov0A, 0.9355, 0.50, 1.000, 214, 214, STRUCTURE OF BACTERIORHDOPSIN TRANSFERRED FROM AMPHIPOL A8-35 TO A LIPIDIC MESOPHASE
199, 5ahzA, 0.9354, 1.56, 0.333, 243, 225, BROMIDE-BOUND FORM OF HALORHODOPSIN FROM HALOBACTERIUM SALINARUM IN A NEW RHOMBOHEDRAL CRYSTAL FORM
200, 5g36A, 0.9352, 1.56, 0.333, 242, 225, YELLOW FORM OF HALORHODOPSIN FROM HALOBACTERIUM SALINARUM IN A NEW RHOMBOHEDRAL CRYSTAL FORM
201, 2jagA, 0.9342, 1.53, 0.329, 242, 225, L1-INTERMEDIATE OF HALORHODOPSIN T203V
202, 2jafA, 0.9338, 1.55, 0.329, 242, 225, GROUND STATE OF HALORHODOPSIN T203V
203, 4qryC, 0.9330, 1.51, 0.316, 259, 225, THE GROUND STATE AND THE N INTERMEDIATE OF PHARAONIS HALORHODOPSIN IN COMPLEX WITH BROMIDE ION
204, 1e12A, 0.9324, 1.58, 0.333, 239, 225, HALORHODOPSIN A LIGHT-DRIVEN CHLORIDE PUMP
205, 3vvkB, 0.9309, 1.53, 0.311, 258, 225, AN M-LIKE REACTION STATE OF THE AZIDE-BOUND PURPLE FORM OF PHARAONIS HALORHODOPSIN
206, 4qryB, 0.9284, 1.56, 0.311, 258, 225, THE GROUND STATE AND THE N INTERMEDIATE OF PHARAONIS HALORHODOPSIN IN COMPLEX WITH BROMIDE ION
207, 3qdcA, 0.9275, 1.44, 0.292, 219, 219, CRYSTAL STRUCTURE OF NATRONOMONAS PHARAONIS SENSORY RHODOPSIN II IN THE ACTIVE STATE
208, 3qapA, 0.9275, 1.44, 0.292, 219, 219, CRYSTAL STRUCTURE OF NATRONOMONAS PHARAONIS SENSORY RHODOPSIN II IN THE GROUND STATE
209, 1h2sA, 0.9247, 1.47, 0.286, 225, 220, MOLECULAR BASIS OF TRANSMENBRANE SIGNALLING BY SENSORY RHODOPSIN II-TRANSDUCER COMPLEX
210, 1h68A, 0.9227, 1.52, 0.294, 218, 218, SENSORY RHODOPSIN II
211, 1gu8A, 0.9227, 1.52, 0.294, 218, 218, SENSORY RHODOPSIN II
212, 1gueA, 0.9224, 1.52, 0.294, 218, 218, SENSORY RHODOPSIN II
213, 1jgjA, 0.9221, 1.19, 0.295, 217, 217, CRYSTAL STRUCTURE OF SENSORY RHODOPSIN II AT 2.4 ANGSTROMS: INSIGHTS INTO COLOR TUNING AND TRANSDUCER INTERACTION
214, 4gycA, 0.9206, 1.43, 0.284, 220, 218, STRUCTURE OF THE SRII(D75N MUTANT)/HTRII COMPLEX IN I212121 SPACE GROUP (U SHAPE)
215, 5jjnA, 0.9200, 1.35, 0.289, 223, 218, STRUCTURE OF THE SRII/HTRII(G83F) COMPLEX IN P212121 SPACE GROUP (V SHAPE)
216, 1s8lA, 0.9191, 1.47, 0.977, 219, 216, ANION-FREE FORM OF THE D85S MUTANT OF BACTERIORHODOPSIN FROM CRYSTALS GROWN IN THE PRESENCE OF HALIDE
217, 5jjeA, 0.9189, 1.46, 0.289, 221, 218, STRUCTURE OF THE SRII/HTRII COMPLEX IN I212121 SPACE GROUP (U SHAPE)
218, 2f95A, 0.9187, 1.39, 0.289, 220, 218, M INTERMEDIATE STRUCTURE OF SENSORY RHODOPSIN II/TRANSDUCER COMPLEX IN COMBINATION WITH THE GROUND STATE STRUCTURE
219, 2f93A, 0.9183, 1.42, 0.289, 220, 218, K INTERMEDIATE STRUCTURE OF SENSORY RHODOPSIN II/TRANSDUCER COMPLEX IN COMBINATION WITH THE GROUND STATE STRUCTURE
220, 1ap9A, 0.9166, 1.66, 1.000, 219, 219, X-RAY STRUCTURE OF BACTERIORHODOPSIN FROM MICROCRYSTALS GROWN IN LIPIDIC CUBIC PHASES
221, 1mgyA, 0.9155, 1.14, 0.986, 216, 213, STRUCTURE OF THE D85S MUTANT OF BACTERIORHODOPSIN WITH BROMIDE BOUND
222, 1s8jA, 0.9150, 1.15, 0.986, 216, 213, NITRATE-BOUND D85S MUTANT OF BACTERIORHODOPSIN
223, 5a44A, 0.9143, 0.58, 1.000, 209, 209, STRUCTURE OF BACTERIORHODOPSIN OBTAINED FROM 20UM CRYSTALS BY MULTI CRYSTAL DATA COLLECTION
224, 1x0i1, 0.9143, 1.20, 0.995, 215, 213, CRYSTAL STRUCTURE OF THE ACID BLUE FORM OF BACTERIORHODOPSIN
225, 5jjnC, 0.9142, 1.18, 0.298, 215, 215, STRUCTURE OF THE SRII/HTRII(G83F) COMPLEX IN P212121 SPACE GROUP (V SHAPE)
226, 5jjjA, 0.9126, 1.42, 0.296, 216, 216, STRUCTURE OF THE SRII/HTRII COMPLEX IN P64 SPACE GROUP (U SHAPE)
227, 1brxA, 0.9126, 0.62, 1.000, 209, 209, BACTERIORHODOPSIN/LIPID COMPLEX
228, 2wjkA, 0.9124, 1.01, 0.995, 210, 210, BACTERIORHODOPSIN MUTANT E204D
229, 2brdA, 0.9103, 1.53, 0.936, 221, 218, CRYSTAL STRUCTURE OF BACTERIORHODOPSIN IN PURPLE MEMBRANE
230, 2ksyA, 0.9065, 1.71, 0.286, 247, 220, SOLUTION NMR STRUCTURE OF SENSORY RHODOPSIN II
231, 5awzA, 0.9038, 1.94, 0.266, 235, 222, CRYSTAL STRUCTURE OF THE CELL-FREE SYNTHESIZED MEMBRANE PROTEIN ACETABULARIA RHODOPSIN I AT 1.57 ANGSTROM
232, 5ax0A, 0.9031, 2.06, 0.278, 234, 223, CRYSTAL STRUCTURE OF THE CELL-FREE SYNTHESIZED MEMBRANE PROTEIN ACETABULARIA RHODOPSIN I AT 1.52 ANGSTROM
233, 5ax1A, 0.9026, 1.96, 0.266, 235, 222, CRYSTAL STRUCTURE OF THE CELL-FREE SYNTHESIZED MEMBRANE PROTEIN ACETABULARIA RHODOPSIN I AT 1.80 ANGSTROM
234, 1jv7A, 0.8953, 1.01, 0.990, 210, 209, BACTERIORHODOPSIN O-LIKE INTERMEDIATE STATE OF THE D85S MUTANT AT 2.25 ANGSTROM RESOLUTION
235, 3am6B, 0.8911, 1.91, 0.307, 224, 218, CRYSTAL STRUCTURE OF THE PROTON PUMPING RHODOPSIN AR2 FROM MARINE ALGA ACETABULARIA ACETABULUM
236, 3am6A, 0.8911, 1.91, 0.307, 224, 218, CRYSTAL STRUCTURE OF THE PROTON PUMPING RHODOPSIN AR2 FROM MARINE ALGA ACETABULARIA ACETABULUM
237, 3am6D, 0.8910, 1.91, 0.307, 224, 218, CRYSTAL STRUCTURE OF THE PROTON PUMPING RHODOPSIN AR2 FROM MARINE ALGA ACETABULARIA ACETABULUM
238, 3am6C, 0.8910, 1.91, 0.307, 224, 218, CRYSTAL STRUCTURE OF THE PROTON PUMPING RHODOPSIN AR2 FROM MARINE ALGA ACETABULARIA ACETABULUM
239, 1jv6A, 0.8908, 1.01, 0.986, 208, 208, BACTERIORHODOPSIN D85S/F219L DOUBLE MUTANT AT 2.00 ANGSTROM RESOLUTION
240, 4tl3B, 0.8652, 1.95, 0.288, 217, 212, MECHANISTIC INSIGHTS FROM THE CRYSTAL STRUCTURE OF AN INWARD PROTON- TRANSPORTING ANABAENA SENSORY RHODOPSIN MUTANT
241, 1xioA, 0.8615, 2.02, 0.288, 217, 212, ANABAENA SENSORY RHODOPSIN
242, 4tl3A, 0.8572, 2.01, 0.289, 216, 211, MECHANISTIC INSIGHTS FROM THE CRYSTAL STRUCTURE OF AN INWARD PROTON- TRANSPORTING ANABAENA SENSORY RHODOPSIN MUTANT
243, 4hyjA, 0.8514, 2.66, 0.287, 236, 216, CRYSTAL STRUCTURE OF EXIGUOBACTERIUM SIBIRICUM RHODOPSIN
244, 5g2cA, 0.8481, 2.46, 0.227, 268, 216, THE CRYSTAL STRUCTURE OF LIGHT-DRIVEN CHLORIDE PUMP CLR (T102D) MUTANT AT PH 4.5.
245, 1c8sA, 0.8469, 0.76, 0.995, 196, 195, BACTERIORHODOPSIN D96N LATE M STATE INTERMEDIATE
246, 4hyjB, 0.8468, 2.19, 0.289, 224, 211, CRYSTAL STRUCTURE OF EXIGUOBACTERIUM SIBIRICUM RHODOPSIN
247, 6eyuB, 0.8461, 2.16, 0.233, 232, 210, CRYSTAL STRUCTURE OF THE INWARD H(+) PUMP XENORHODOPSIN
248, 5b2nA, 0.8461, 2.52, 0.230, 263, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN CHLORIDE ION-PUMPING RHODOPSIN CLP FROM NONLABENS MARINUS
249, 5g28A, 0.8460, 2.45, 0.231, 264, 216, THE CRYSTAL STRUCTURE OF LIGHT-DRIVEN CHLORIDE PUMP CLR AT PH 6.0.
250, 6eyuC, 0.8459, 2.15, 0.233, 229, 210, CRYSTAL STRUCTURE OF THE INWARD H(+) PUMP XENORHODOPSIN
251, 5fjgA, 0.8458, 2.47, 0.231, 269, 216, THE CRYSTAL STRUCTURE OF LIGHT-DRIVEN CHLORIDE PUMP CLR IN PH 4.5.
252, 5g2aA, 0.8457, 2.46, 0.231, 264, 216, THE CRYSTAL STRUCTURE OF LIGHT-DRIVEN CHLORIDE PUMP CLR AT PH 6.0 WITH BROMIDE ION.
253, 5g2dA, 0.8455, 2.48, 0.227, 267, 216, THE CRYSTAL STRUCTURE OF LIGHT-DRIVEN CHLORIDE PUMP CLR (T102N) MUTANT AT PH 4.5.
254, 5g54A, 0.8454, 2.47, 0.231, 269, 216, THE CRYSTAL STRUCTURE OF LIGHT-DRIVEN CHLORIDE PUMP CLR AT PH 4.5
255, 6eyuA, 0.8453, 2.16, 0.238, 232, 210, CRYSTAL STRUCTURE OF THE INWARD H(+) PUMP XENORHODOPSIN
256, 4xtnI, 0.8389, 2.82, 0.212, 270, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 4.9
257, 3x3cA, 0.8384, 2.78, 0.221, 271, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN NEUTRAL STATE
258, 4xtnE, 0.8383, 2.83, 0.212, 271, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 4.9
259, 3x3bA, 0.8374, 2.74, 0.221, 271, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN ACIDIC STATE
260, 4xtoB, 0.8361, 2.74, 0.213, 266, 216, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 5.6
261, 4xtnF, 0.8354, 2.85, 0.212, 270, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 4.9
262, 4xtnB, 0.8351, 2.89, 0.212, 269, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 4.9
263, 4xtlA, 0.8350, 2.78, 0.222, 269, 216, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE MONOMERIC BLUE FORM PH 4.3
264, 4xtnG, 0.8349, 2.86, 0.212, 270, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 4.9
265, 4xtnC, 0.8342, 2.86, 0.212, 270, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 4.9
266, 5jrfA, 0.8339, 2.74, 0.222, 267, 216, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 BOUND WITH IODIDE IONS
267, 4xtoA, 0.8335, 2.77, 0.213, 265, 216, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 5.6
268, 4xtoC, 0.8330, 2.81, 0.218, 263, 216, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 5.6
269, 6eidB, 0.8327, 2.52, 0.151, 250, 219, CRYSTAL STRUCTURE OF WILD-TYPE CHANNELRHODOPSIN 2
270, 6eidA, 0.8327, 2.51, 0.151, 246, 219, CRYSTAL STRUCTURE OF WILD-TYPE CHANNELRHODOPSIN 2
271, 4xtnA, 0.8325, 2.88, 0.217, 272, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 4.9
272, 4xtnJ, 0.8324, 2.89, 0.212, 271, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 4.9
273, 4xtnD, 0.8319, 2.89, 0.212, 270, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 4.9
274, 4xtnH, 0.8316, 2.91, 0.212, 272, 217, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 4.9
275, 4xtoE, 0.8312, 2.77, 0.219, 265, 215, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 5.6
276, 5azdA, 0.8301, 2.66, 0.260, 250, 215, CRYSTAL STRUCTURE OF THERMOPHILIC RHODOPSIN.
277, 5azdD, 0.8300, 2.66, 0.260, 249, 215, CRYSTAL STRUCTURE OF THERMOPHILIC RHODOPSIN.
278, 5azdC, 0.8261, 2.63, 0.262, 250, 214, CRYSTAL STRUCTURE OF THERMOPHILIC RHODOPSIN.
279, 3ug9A, 0.8254, 2.26, 0.174, 280, 213, CRYSTAL STRUCTURE OF THE CLOSED STATE OF CHANNELRHODOPSIN
280, 5azdB, 0.8247, 2.65, 0.266, 249, 214, CRYSTAL STRUCTURE OF THERMOPHILIC RHODOPSIN.
281, 4xtoD, 0.8230, 2.75, 0.211, 262, 213, CRYSTAL STRUCTURE OF THE LIGHT-DRIVEN SODIUM PUMP KR2 IN THE PENTAMERIC RED FORM PH 5.6
282, 4yziA, 0.8204, 2.36, 0.169, 289, 213, CRYSTAL STRUCTURE OF BLUE-SHIFTED CHANNELRHODOPSIN MUTANT (T198G/G202A)
283, 6eigA, 0.8182, 2.40, 0.159, 249, 214, CRYSTAL STRUCTURE OF N24Q/C128T MUTANT OF CHANNELRHODOPSIN 2
284, 3ddlA, 0.8182, 2.77, 0.219, 252, 215, CRYSTALLOGRAPHIC STRUCTURE OF XANTHORHODOPSIN A LIGHT-DRIVEN ION PUMP WITH DUAL CHROMOPHORE
285, 6eigB, 0.8176, 2.42, 0.159, 249, 214, CRYSTAL STRUCTURE OF N24Q/C128T MUTANT OF CHANNELRHODOPSIN 2
286, 3ddlB, 0.8150, 2.83, 0.223, 250, 215, CRYSTALLOGRAPHIC STRUCTURE OF XANTHORHODOPSIN A LIGHT-DRIVEN ION PUMP WITH DUAL CHROMOPHORE
287, 4knfE, 0.8134, 2.97, 0.260, 230, 215, CRYSTAL STRUCTURE OF A BLUE-LIGHT ABSORBING PROTEORHODOPSIN DOUBLE- MUTANT D97N/Q105L FROM HOT75
288, 4knfA, 0.8121, 2.86, 0.262, 231, 214, CRYSTAL STRUCTURE OF A BLUE-LIGHT ABSORBING PROTEORHODOPSIN DOUBLE- MUTANT D97N/Q105L FROM HOT75
289, 5jsiA, 0.8113, 2.56, 0.220, 214, 209, STRUCTURE OF MEMBRANE PROTEIN
290, 5jsiB, 0.8107, 2.59, 0.225, 214, 209, STRUCTURE OF MEMBRANE PROTEIN
291, 4knfC, 0.8091, 2.91, 0.262, 232, 214, CRYSTAL STRUCTURE OF A BLUE-LIGHT ABSORBING PROTEORHODOPSIN DOUBLE- MUTANT D97N/Q105L FROM HOT75
292, 4knfD, 0.8048, 3.02, 0.268, 229, 213, CRYSTAL STRUCTURE OF A BLUE-LIGHT ABSORBING PROTEORHODOPSIN DOUBLE- MUTANT D97N/Q105L FROM HOT75
293, 4knfB, 0.7978, 2.86, 0.267, 224, 210, CRYSTAL STRUCTURE OF A BLUE-LIGHT ABSORBING PROTEORHODOPSIN DOUBLE- MUTANT D97N/Q105L FROM HOT75
294, 4jq6B, 0.7839, 2.75, 0.256, 203, 203, CRYSTAL STRUCTURE OF BLUE LIGHT-ABSORBING PROTEORHODOPSIN FROM MED12 AT 2.3 ANGSTROM
295, 4klyB, 0.7773, 2.85, 0.250, 222, 204, CRYSTAL STRUCTURE OF A BLUE-LIGHT ABSORBING PROTEORHODOPSIN MUTANT D97N FROM HOT75
296, 4klyC, 0.7717, 2.90, 0.245, 220, 204, CRYSTAL STRUCTURE OF A BLUE-LIGHT ABSORBING PROTEORHODOPSIN MUTANT D97N FROM HOT75
297, 5uk6C, 0.7707, 3.24, 0.273, 228, 216, STRUCTURE OF ANABAENA SENSORY RHODOPSIN DETERMINED BY SOLID STATE NMR SPECTROSCOPY AND DEER
298, 2m3gB, 0.7704, 3.34, 0.269, 229, 219, STRUCTURE OF ANABAENA SENSORY RHODOPSIN DETERMINED BY SOLID STATE NMR SPECTROSCOPY
299, 5uk6B, 0.7701, 3.25, 0.273, 228, 216, STRUCTURE OF ANABAENA SENSORY RHODOPSIN DETERMINED BY SOLID STATE NMR SPECTROSCOPY AND DEER
300, 5uk6A, 0.7698, 3.25, 0.273, 228, 216, STRUCTURE OF ANABAENA SENSORY RHODOPSIN DETERMINED BY SOLID STATE NMR SPECTROSCOPY AND DEER
301, 4klyE, 0.7659, 2.80, 0.255, 216, 200, CRYSTAL STRUCTURE OF A BLUE-LIGHT ABSORBING PROTEORHODOPSIN MUTANT D97N FROM HOT75
302, 4klyA, 0.7657, 2.91, 0.257, 218, 202, CRYSTAL STRUCTURE OF A BLUE-LIGHT ABSORBING PROTEORHODOPSIN MUTANT D97N FROM HOT75
303, 2m3gC, 0.7657, 3.28, 0.276, 229, 217, STRUCTURE OF ANABAENA SENSORY RHODOPSIN DETERMINED BY SOLID STATE NMR SPECTROSCOPY
304, 4jq6C, 0.7575, 2.78, 0.254, 199, 197, CRYSTAL STRUCTURE OF BLUE LIGHT-ABSORBING PROTEORHODOPSIN FROM MED12 AT 2.3 ANGSTROM
305, 4klyD, 0.7561, 2.78, 0.264, 211, 197, CRYSTAL STRUCTURE OF A BLUE-LIGHT ABSORBING PROTEORHODOPSIN MUTANT D97N FROM HOT75
306, 2m3gA, 0.7549, 3.57, 0.271, 229, 218, STRUCTURE OF ANABAENA SENSORY RHODOPSIN DETERMINED BY SOLID STATE NMR SPECTROSCOPY
307, 4jq6A, 0.7497, 2.62, 0.259, 197, 193, CRYSTAL STRUCTURE OF BLUE LIGHT-ABSORBING PROTEORHODOPSIN FROM MED12 AT 2.3 ANGSTROM
308, 5lxaA, 0.7051, 3.99, 0.065, 284, 214, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 3.0 ANGSTROM RESOLUTION
309, 3wxwA, 0.7027, 3.87, 0.076, 283, 211, CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 2
310, 1brdA, 0.6990, 1.82, 0.841, 170, 170, MODEL FOR THE STRUCTURE OF BACTERIORHODOPSIN BASED ON HIGH-RESOLUTION ELECTRON CRYO-MICROSCOPY
311, 1hzxA, 0.6955, 4.04, 0.101, 340, 217, CRYSTAL STRUCTURE OF BOVINE RHODOPSIN
312, 3c9lA, 0.6926, 4.09, 0.092, 328, 217, STRUCTURE OF GROUND-STATE BOVINE RHODOSPIN IN A HEXAGONAL CRYSTAL FORM
313, 1gzmA, 0.6926, 4.09, 0.092, 328, 217, STRUCTURE OF BOVINE RHODOPSIN IN A TRIGONAL CRYSTAL FORM
314, 3oaxA, 0.6922, 4.10, 0.101, 348, 217, CRYSTAL STRUCTURE OF BOVINE RHODOPSIN WITH BETA-IONONE
315, 2g87B, 0.6916, 4.07, 0.092, 348, 217, CRYSTALLOGRAPHIC MODEL OF BATHORHODOPSIN
316, 1u19A, 0.6916, 4.13, 0.101, 348, 217, CRYSTAL STRUCTURE OF BOVINE RHODOPSIN AT 2.2 ANGSTROMS RESOLUTION
317, 1l9hA, 0.6916, 4.08, 0.092, 340, 217, CRYSTAL STRUCTURE OF BOVINE RHODOPSIN AT 2.6 ANGSTROMS RESOLUTION
318, 2g87A, 0.6913, 4.08, 0.101, 348, 217, CRYSTALLOGRAPHIC MODEL OF BATHORHODOPSIN
319, 2pedB, 0.6906, 4.08, 0.092, 348, 217, CRYSTALLOGRAPHIC MODEL OF 9-CIS-RHODOPSIN
320, 1hzxB, 0.6898, 4.12, 0.102, 301, 216, CRYSTAL STRUCTURE OF BOVINE RHODOPSIN
321, 2i35A, 0.6891, 4.14, 0.101, 328, 217, CRYSTAL STRUCTURE OF RHOMBOHEDRAL CRYSTAL FORM OF GROUND-STATE RHODOPSIN
322, 1l9hB, 0.6891, 3.98, 0.103, 301, 214, CRYSTAL STRUCTURE OF BOVINE RHODOPSIN AT 2.6 ANGSTROMS RESOLUTION
323, 1f88B, 0.6889, 4.19, 0.093, 305, 216, CRYSTAL STRUCTURE OF BOVINE RHODOPSIN
324, 4ww3A, 0.6886, 4.08, 0.111, 350, 216, CRYSTAL STRUCTURE OF THE LUMI INTERMEDIATE OF SQUID RHODOPSIN
325, 3wxvA, 0.6882, 4.00, 0.085, 283, 211, CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1
326, 3capA, 0.6880, 4.03, 0.107, 326, 215, CRYSTAL STRUCTURE OF NATIVE OPSIN: THE G PROTEIN-COUPLED RECEPTOR RHODOPSIN IN ITS LIGAND-FREE STATE
327, 2z73A, 0.6878, 4.11, 0.111, 350, 216, CRYSTAL STRUCTURE OF SQUID RHODOPSIN
328, 2ksbA, 0.6875, 4.17, 0.096, 363, 218, SUBSTANCE P IN ISOTROPIC Q=0.25 DMPC/CHAPS/GM1 BICELLES AS A LIGAND FOR NK1R
329, 2ksaA, 0.6875, 4.17, 0.096, 363, 218, SUBSTANCE P IN DMPC/CHAPS ISOTROPIC Q=0.25 BICELLES AS A LIGAND FOR NK1R
330, 2ks9A, 0.6875, 4.17, 0.096, 363, 218, SOLUTION CONFORMATION OF SUBSTANCE P IN WATER COMPLEXED WITH NK1R
331, 2hpyB, 0.6871, 4.16, 0.101, 348, 217, CRYSTALLOGRAPHIC MODEL OF LUMIRHODOPSIN
332, 3c9mA, 0.6870, 4.10, 0.102, 326, 216, STRUCTURE OF A MUTANT BOVINE RHODOPSIN IN HEXAGONAL CRYSTAL FORM
333, 3capB, 0.6869, 4.05, 0.107, 326, 215, CRYSTAL STRUCTURE OF NATIVE OPSIN: THE G PROTEIN-COUPLED RECEPTOR RHODOPSIN IN ITS LIGAND-FREE STATE
334, 4j4qA, 0.6863, 3.95, 0.098, 326, 214, CRYSTAL STRUCTURE OF ACTIVE CONFORMATION OF GPCR OPSIN STABILIZED BY OCTYLGLUCOSIDE
335, 5te3A, 0.6861, 4.03, 0.102, 326, 215, CRYSTAL STRUCTURE OF BOS TAURUS OPSIN AT 2.7 ANGSTROM
336, 4ww3B, 0.6860, 4.13, 0.111, 347, 216, CRYSTAL STRUCTURE OF THE LUMI INTERMEDIATE OF SQUID RHODOPSIN
337, 3dqbA, 0.6859, 3.98, 0.103, 326, 214, CRYSTAL STRUCTURE OF THE ACTIVE G-PROTEIN-COUPLED RECEPTOR OPSIN IN COMPLEX WITH A C-TERMINAL PEPTIDE DERIVED FROM THE GALPHA SUBUNIT OF TRANSDUCIN
338, 3aymB, 0.6853, 4.14, 0.111, 347, 216, CRYSTAL STRUCTURE OF THE BATHO INTERMEDIATE OF SQUID RHODOPSIN
339, 3aynB, 0.6850, 4.14, 0.111, 347, 216, CRYSTAL STRUCTURE OF SQUID ISORHODOPSIN
340, 2z73B, 0.6846, 4.15, 0.111, 347, 216, CRYSTAL STRUCTURE OF SQUID RHODOPSIN
341, 2ziyA, 0.6845, 4.20, 0.111, 370, 217, CRYSTAL STRUCTURE OF SQUID RHODOPSIN
342, 4a4mA, 0.6840, 4.06, 0.107, 326, 215, CRYSTAL STRUCTURE OF THE LIGHT-ACTIVATED CONSTITUTIVELY ACTIVE N2CM257YD282C RHODOPSIN MUTANT IN COMPLEX WITH A PEPTIDE RESEMBLING THE C-TERMINUS OF THE GALPHA-PROTEIN SUBUNIT (GACT)
343, 3pqrA, 0.6837, 4.04, 0.102, 326, 215, CRYSTAL STRUCTURE OF METARHODOPSIN II IN COMPLEX WITH A C-TERMINAL PEPTIDE DERIVED FROM THE GALPHA SUBUNIT OF TRANSDUCIN
344, 4x1hA, 0.6836, 4.05, 0.102, 326, 215, OPSIN/G(ALPHA) PEPTIDE COMPLEX STABILIZED BY NONYL-GLUCOSIDE
345, 5dysA, 0.6835, 4.12, 0.107, 326, 215, CRYSTAL STRUCTURE OF T94I RHODOPSIN MUTANT
346, 5lwyA, 0.6829, 4.07, 0.083, 285, 216, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID
347, 5wktA, 0.6827, 4.06, 0.102, 326, 215, 3.2-ANGSTROM IN SITU MYLAR STRUCTURE OF BOVINE OPSIN AT 100 K
348, 5en0A, 0.6825, 4.11, 0.107, 326, 215, CRYSTAL STRUCTURE OF T94I RHODOPSIN MUTANT
349, 4pxfA, 0.6821, 4.10, 0.107, 325, 215, CRYSTAL STRUCTURE OF THE ACTIVE G-PROTEIN-COUPLED RECEPTOR OPSIN IN COMPLEX WITH THE FINGER-LOOP PEPTIDE DERIVED FROM THE FULL-LENGTH ARRESTIN-1
350, 4bezA, 0.6810, 4.21, 0.102, 326, 216, NIGHT BLINDNESS CAUSING G90D RHODOPSIN IN THE ACTIVE CONFORMATION
351, 4beyA, 0.6804, 4.21, 0.097, 326, 216, NIGHT BLINDNESS CAUSING G90D RHODOPSIN IN COMPLEX WITH GACT2 PEPTIDE
352, 5lx9A, 0.6802, 4.09, 0.083, 283, 216, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 2.4 ANGSTROM RESOLUTION
353, 3pxoA, 0.6802, 4.22, 0.097, 326, 216, CRYSTAL STRUCTURE OF METARHODOPSIN II
354, 2x72A, 0.6793, 4.12, 0.107, 326, 215, CRYSTAL STRUCTURE OF THE CONSTITUTIVELY ACTIVE E113QN2C D282C RHODOPSIN MUTANT WITH BOUND GALPHACT PEPTIDE.
355, 5w0pD, 0.6788, 4.17, 0.097, 773, 216, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
356, 5lxgA, 0.6788, 4.15, 0.090, 282, 211, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1 IN AN OPEN CONFORMATION
357, 2i36A, 0.6777, 4.17, 0.102, 326, 216, CRYSTAL STRUCTURE OF TRIGONAL CRYSTAL FORM OF GROUND-STATE RHODOPSIN
358, 2i36C, 0.6776, 4.17, 0.102, 322, 216, CRYSTAL STRUCTURE OF TRIGONAL CRYSTAL FORM OF GROUND-STATE RHODOPSIN
359, 5w0pB, 0.6775, 4.11, 0.093, 802, 215, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
360, 2ydvA, 0.6765, 4.35, 0.089, 315, 213, THERMOSTABILISED HUMAN A2A RECEPTOR WITH NECA BOUND
361, 5nm4A, 0.6764, 4.36, 0.098, 382, 215, A2A ADENOSINE RECEPTOR ROOM-TEMPERATURE STRUCTURE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
362, 2i36B, 0.6764, 4.20, 0.102, 314, 216, CRYSTAL STRUCTURE OF TRIGONAL CRYSTAL FORM OF GROUND-STATE RHODOPSIN
363, 5dgyC, 0.6763, 4.14, 0.093, 789, 215, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
364, 4zwjC, 0.6763, 4.14, 0.093, 789, 215, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
365, 5mzjA, 0.6762, 4.27, 0.099, 386, 213, CRYSTAL STRUCTURE OF STABILIZED A2A ADENOSINE RECEPTOR A2AR-STAR2-BRIL IN COMPLEX WITH THEOPHYLLINE AT 2.0A RESOLUTION
366, 5w0pC, 0.6761, 4.13, 0.098, 849, 215, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
367, 5jtbA, 0.6761, 4.41, 0.102, 388, 215, CRYSTAL STRUCTURE OF THE CHIMERIC PROTEIN OF A2AAR-BRIL WITH BOUND IODIDE IONS
368, 5w0pA, 0.6757, 4.12, 0.093, 847, 215, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
369, 5olvA, 0.6755, 4.41, 0.098, 388, 215, STRUCTURE OF THE A2A-STAR2-BRIL562-LUAA47070 COMPLEX AT 2.0A OBTAINED FROM IN MESO SOAKING EXPERIMENTS.
370, 4bv0A, 0.6755, 3.96, 0.072, 297, 208, HIGH RESOLUTION STRUCTURE OF EVOLVED AGONIST-BOUND NEUROTENSIN RECEPTOR 1 MUTANT WITHOUT LYSOZYME FUSION
371, 5iu7A, 0.6753, 4.37, 0.098, 392, 215, CRYSTAL STRUCTURE OF STABILIZED A2A ADENOSINE RECEPTOR A2AR-STAR2-BRIL IN COMPLEX WITH COMPOUND 12C AT 1.9A RESOLUTION
372, 5om4A, 0.6752, 4.29, 0.099, 389, 213, STRUCTURE OF THE A2A-STAR2-BRIL562-COMPOUND 4E COMPLEX AT 1.86A OBTAINED FROM IN MESO SOAKING EXPERIMENTS (24 HOUR SOAK).
373, 5dgyA, 0.6751, 4.13, 0.093, 833, 215, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
374, 4zwjA, 0.6751, 4.13, 0.093, 833, 215, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
375, 5nlxA, 0.6750, 4.35, 0.103, 382, 214, A2A ADENOSINE RECEPTOR ROOM-TEMPERATURE STRUCTURE DETERMINED BY SERIAL MILLISECOND CRYSTALLOGRAPHY
376, 5om1A, 0.6748, 4.30, 0.099, 388, 213, STRUCTURE OF THE A2A-STAR2-BRIL562-COMPOUND 4E COMPLEX AT 2.1A OBTAINED FROM IN MESO SOAKING EXPERIMENTS (1 HOUR SOAK).
377, 5olgA, 0.6747, 4.37, 0.098, 390, 215, STRUCTURE OF THE A2A-STAR2-BRIL562-ZM241385 COMPLEX AT 1.86A OBTAINED FROM IN MESO SOAKING EXPERIMENTS.
378, 5mzpA, 0.6747, 4.28, 0.099, 389, 213, CRYSTAL STRUCTURE OF STABILIZED A2A ADENOSINE RECEPTOR A2AR-STAR2-BRIL IN COMPLEX WITH CAFFEINE AT 2.1A RESOLUTION
379, 5iu4A, 0.6747, 4.37, 0.098, 388, 215, CRYSTAL STRUCTURE OF STABILIZED A2A ADENOSINE RECEPTOR A2AR-STAR2-BRIL IN COMPLEX WITH ZM241385 AT 1.7A RESOLUTION
380, 5nm2A, 0.6746, 4.37, 0.098, 388, 215, A2A ADENOSINE RECEPTOR CRYO STRUCTURE
381, 4eiyA, 0.6746, 4.28, 0.103, 390, 213, CRYSTAL STRUCTURE OF THE CHIMERIC PROTEIN OF A2AAR-BRIL IN COMPLEX WITH ZM241385 AT 1.8A RESOLUTION
382, 5vraA, 0.6745, 4.29, 0.103, 390, 213, 2.35-ANGSTROM IN SITU MYLAR STRUCTURE OF HUMAN A2A ADENOSINE RECEPTOR AT 100 K
383, 5iubA, 0.6745, 4.40, 0.098, 388, 215, CRYSTAL STRUCTURE OF STABILIZED A2A ADENOSINE RECEPTOR A2AR-STAR2-BRIL IN COMPLEX WITH COMPOUND 12X AT 2.1A RESOLUTION
384, 5iu8A, 0.6744, 4.38, 0.098, 387, 215, CRYSTAL STRUCTURE OF STABILIZED A2A ADENOSINE RECEPTOR A2AR-STAR2-BRIL IN COMPLEX WITH COMPOUND 12F AT 2.0A RESOLUTION
385, 5olzA, 0.6741, 4.38, 0.103, 387, 213, STRUCTURE OF THE A2A-STAR2-BRIL562-COMPOUND 4E COMPLEX AT 1.9A OBTAINED FROM BESPOKE CO-CRYSTALLISATION EXPERIMENTS.
386, 3zevA, 0.6741, 3.90, 0.082, 307, 208, STRUCTURE OF THERMOSTABLE AGONIST-BOUND NEUROTENSIN RECEPTOR 1 MUTANT WITHOUT LYSOZYME FUSION
387, 5oloA, 0.6740, 4.38, 0.098, 385, 214, STRUCTURE OF THE A2A-STAR2-BRIL562-TOZADENANT COMPLEX AT 3.1A OBTAINED FROM IN MESO SOAKING EXPERIMENTS.
388, 5iuaA, 0.6740, 4.38, 0.098, 388, 215, CRYSTAL STRUCTURE OF STABILIZED A2A ADENOSINE RECEPTOR A2AR-STAR2-BRIL IN COMPLEX WITH COMPOUND 12B AT 2.2A RESOLUTION
389, 5k2aA, 0.6737, 4.31, 0.103, 398, 213, 2.5 ANGSTROM A2A ADENOSINE RECEPTOR STRUCTURE WITH SULFUR SAD PHASING USING XFEL DATA
390, 6aqfA, 0.6736, 4.37, 0.103, 390, 214, CRYSTAL STRUCTURE OF A2AAR-BRIL IN COMPLEX WITH THE ANTAGONIST ZM241385 PRODUCED FROM PICHIA PASTORIS
391, 5dhhA, 0.6735, 4.36, 0.112, 282, 215, THE CRYSTAL STRUCTURE OF NOCICEPTIN/ORPHANIN FQ PEPTIDE RECEPTOR (NOP) IN COMPLEX WITH SB-612111 (PSI COMMUNITY TARGET)
392, 5k2cA, 0.6734, 4.30, 0.103, 396, 213, 1.9 ANGSTROM A2A ADENOSINE RECEPTOR STRUCTURE WITH SULFUR SAD PHASING AND PHASE EXTENSION USING XFEL DATA
393, 5k2bA, 0.6734, 4.31, 0.103, 394, 213, 2.5 ANGSTROM A2A ADENOSINE RECEPTOR STRUCTURE WITH MR PHASING USING XFEL DATA
394, 5n2rA, 0.6732, 4.31, 0.099, 388, 213, CRYSTAL STRUCTURE OF STABILIZED A2A ADENOSINE RECEPTOR A2AR-STAR2-BRIL IN COMPLEX WITH PSB36 AT 2.8A RESOLUTION
395, 5k2dA, 0.6732, 4.27, 0.104, 395, 212, 1.9A ANGSTROM A2A ADENOSINE RECEPTOR STRUCTURE WITH MR PHASING USING XFEL DATA
396, 5dgyD, 0.6730, 4.23, 0.097, 833, 216, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
397, 4zwjD, 0.6730, 4.23, 0.097, 833, 216, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
398, 5dgyB, 0.6728, 4.34, 0.088, 673, 217, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
399, 4zwjB, 0.6728, 4.34, 0.088, 673, 217, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
400, 5uviA, 0.6721, 4.33, 0.103, 391, 213, SERIAL MILLISECOND CRYSTALLOGRAPHY OF MEMBRANE AND SOLUBLE PROTEIN MICRO-CRYSTALS USING SYNCHROTRON RADIATION
401, 5dhgB, 0.6713, 4.33, 0.112, 379, 214, THE CRYSTAL STRUCTURE OF NOCICEPTIN/ORPHANIN FQ PEPTIDE RECEPTOR (NOP) IN COMPLEX WITH C-35 (PSI COMMUNITY TARGET)
402, 5olhA, 0.6712, 4.30, 0.099, 390, 213, STRUCTURE OF THE A2A-STAR2-BRIL562-VIPADENANT COMPLEX AT 2.6A OBTAINED FROM IN MESO SOAKING EXPERIMENTS.
403, 4bv0B, 0.6712, 3.97, 0.087, 302, 208, HIGH RESOLUTION STRUCTURE OF EVOLVED AGONIST-BOUND NEUROTENSIN RECEPTOR 1 MUTANT WITHOUT LYSOZYME FUSION
404, 4ug2A, 0.6711, 4.52, 0.093, 292, 215, THERMOSTABILISED HUMAN A2A RECEPTOR WITH CGS21680 BOUND
405, 4ea3A, 0.6706, 4.46, 0.112, 278, 215, STRUCTURE OF THE N/OFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE MIMETIC
406, 2i37B, 0.6704, 4.28, 0.102, 319, 216, CRYSTAL STRUCTURE OF A PHOTOACTIVATED RHODOPSIN
407, 4ug2B, 0.6703, 4.53, 0.093, 276, 215, THERMOSTABILISED HUMAN A2A RECEPTOR WITH CGS21680 BOUND
408, 2ydoA, 0.6701, 4.45, 0.089, 309, 213, THERMOSTABILISED HUMAN A2A RECEPTOR WITH ADENOSINE BOUND
409, 2l6xA, 0.6701, 4.08, 0.192, 235, 214, SOLUTION NMR STRUCTURE OF PROTEORHODOPSIN.
410, 4ea3B, 0.6695, 4.41, 0.107, 376, 214, STRUCTURE OF THE N/OFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE MIMETIC
411, 5dhgA, 0.6694, 4.42, 0.112, 281, 214, THE CRYSTAL STRUCTURE OF NOCICEPTIN/ORPHANIN FQ PEPTIDE RECEPTOR (NOP) IN COMPLEX WITH C-35 (PSI COMMUNITY TARGET)
412, 4buoB, 0.6691, 4.41, 0.147, 314, 217, HIGH RESOLUTION STRUCTURE OF THERMOSTABLE AGONIST-BOUND NEUROTENSIN RECEPTOR 1 MUTANT WITHOUT LYSOZYME FUSION
413, 3zevB, 0.6680, 4.43, 0.147, 304, 217, STRUCTURE OF THERMOSTABLE AGONIST-BOUND NEUROTENSIN RECEPTOR 1 MUTANT WITHOUT LYSOZYME FUSION
414, 1l0mA, 0.6676, 4.03, 0.912, 212, 204, SOLUTION STRUCTURE OF BACTERIORHODOPSIN
415, 5uenB, 0.6673, 4.53, 0.088, 383, 217, CRYSTAL STRUCTURE OF THE HUMAN ADENOSINE A1 RECEPTOR A1AR-BRIL IN COMPLEX WITH THE COVALENT ANTAGONIST DU172 AT 3.2A RESOLUTION
416, 6c1rB, 0.6671, 4.28, 0.084, 370, 214, CRYSTAL STRUCTURE OF HUMAN C5A RECEPTOR IN COMPLEX WITH AN ORTHOSTERIC ANTAGONIST PMX53 AND AN ALLOSTERIC ANTAGONIST AVACOPAN 
417, 2i37A, 0.6670, 4.37, 0.097, 317, 216, CRYSTAL STRUCTURE OF A PHOTOACTIVATED RHODOPSIN
418, 5ws3A, 0.6667, 4.43, 0.093, 506, 216, CRYSTAL STRUCTURES OF HUMAN OREXIN 2 RECEPTOR BOUND TO THE SELECTIVE ANTAGONIST EMPA DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY AT SACLA
419, 4uhrA, 0.6658, 4.51, 0.094, 310, 213, THERMOSTABILISED HUMAN A2A RECEPTOR WITH CGS21680 BOUND
420, 5unhA, 0.6653, 4.37, 0.057, 385, 210, SYNCHROTRON STRUCTURE OF HUMAN ANGIOTENSIN II TYPE 2 RECEPTOR IN COMPLEX WITH COMPOUND 2 (N-[(FURAN-2-YL)METHYL]-N-(4-OXO-2-PROPYL-3- {[2 -(2H-TETRAZOL-5-YL)[11 - BIPHENYL]-4-YL]METHYL}-34- DIHYDROQUINAZOLIN-6-YL)BENZAMIDE)
421, 6d32A, 0.6652, 4.43, 0.056, 573, 214, CRYSTAL STRUCTURE OF XENOPUS SMOOTHENED IN COMPLEX WITH CYCLOPAMINE 
422, 5uenA, 0.6652, 4.47, 0.088, 384, 216, CRYSTAL STRUCTURE OF THE HUMAN ADENOSINE A1 RECEPTOR A1AR-BRIL IN COMPLEX WITH THE COVALENT ANTAGONIST DU172 AT 3.2A RESOLUTION
423, 6d35A, 0.6649, 4.42, 0.056, 581, 214, CRYSTAL STRUCTURE OF XENOPUS SMOOTHENED IN COMPLEX WITH CHOLESTEROL 
424, 4n4wA, 0.6649, 4.49, 0.083, 457, 216, STRUCTURE OF THE HUMAN SMOOTHENED RECEPTOR IN COMPLEX WITH SANT-1.
425, 4bwbA, 0.6646, 4.42, 0.148, 305, 216, STRUCTURE OF EVOLVED AGONIST-BOUND NEUROTENSIN RECEPTOR 1 MUTANT WITHOUT LYSOZYME FUSION
426, 5l7iA, 0.6645, 4.57, 0.083, 564, 216, STRUCTURE OF HUMAN SMOOTHENED IN COMPLEX WITH VISMODEGIB
427, 1jfpA, 0.6639, 3.96, 0.077, 309, 209, STRUCTURE OF BOVINE RHODOPSIN (DARK ADAPTED)
428, 5o9hB, 0.6638, 4.32, 0.093, 295, 214, CRYSTAL STRUCTURE OF THERMOSTABILISED HUMAN C5A ANAPHYLATOXIN CHEMOTACTIC RECEPTOR 1 (C5AR) IN COMPLEX WITH NDT9513727
429, 5wf5A, 0.6635, 4.56, 0.103, 444, 214, AGONIST BOUND HUMAN A2A ADENOSINE RECEPTOR WITH D52N MUTATION AT 2.60 A RESOLUTION
430, 3qakA, 0.6617, 4.54, 0.114, 444, 211, AGONIST BOUND STRUCTURE OF THE HUMAN ADENOSINE A2A RECEPTOR
431, 5ungB, 0.6616, 4.51, 0.061, 410, 212, XFEL STRUCTURE OF HUMAN ANGIOTENSIN II TYPE 2 RECEPTOR (ORTHORHOMBIC FORM) IN COMPLEX WITH COMPOUND 1 (N-BENZYL-N-(2-ETHYL-4-OXO-3-{[2 - (2H-TETRAZOL-5-YL)[11 -BIPHENYL]-4-YL] METHYL}-34- DIHYDROQUINAZOLIN-6-YL)THIOPHENE-2-CARBOXAMIDE)
432, 6c1qB, 0.6613, 4.27, 0.089, 373, 213, CRYSTAL STRUCTURE OF HUMAN C5A RECEPTOR IN COMPLEX WITH AN ORTHOSTERIC ANTAGONIST PMX53 AND AN ALLOSTERIC ANTAGONIST NDT9513727 
433, 5unfB, 0.6612, 4.52, 0.060, 399, 217, XFEL STRUCTURE OF HUMAN ANGIOTENSIN II TYPE 2 RECEPTOR (MONOCLINIC FORM) IN COMPLEX WITH COMPOUND 1 (N-BENZYL-N-(2-ETHYL-4-OXO-3-{[2 - (2H-TETRAZOL-5-YL)[11 -BIPHENYL]-4-YL])
434, 5wf6A, 0.6609, 4.50, 0.105, 441, 210, AGONIST BOUND HUMAN A2A ADENOSINE RECEPTOR WITH S91A MUTATION AT 2.90 A RESOLUTION
435, 4s0vA, 0.6604, 4.37, 0.099, 478, 213, CRYSTAL STRUCTURE OF THE HUMAN OX2 OREXIN RECEPTOR BOUND TO THE INSOMNIA DRUG SUVOREXANT
436, 6gdgA, 0.6601, 4.55, 0.109, 264, 211, CRYO-EM STRUCTURE OF THE ADENOSINE A2A RECEPTOR BOUND TO A MINIGS HETEROTRIMER 
437, 6fk9A, 0.6599, 4.40, 0.089, 326, 213, CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS09
438, 4pxzA, 0.6595, 4.36, 0.117, 392, 214, CRYSTAL STRUCTURE OF P2Y12 RECEPTOR IN COMPLEX WITH 2MESADP
439, 4qimA, 0.6593, 4.45, 0.070, 457, 213, STRUCTURE OF THE HUMAN SMOOTHENED RECEPTOR IN COMPLEX WITH ANTA XV
440, 5zkqA, 0.6592, 4.14, 0.092, 279, 207, CRYSTAL STRUCTURE OF THE HUMAN PLATELET-ACTIVATING FACTOR RECEPTOR IN COMPLEX WITH ABT-491 
441, 4bwbB, 0.6592, 4.52, 0.147, 300, 217, STRUCTURE OF EVOLVED AGONIST-BOUND NEUROTENSIN RECEPTOR 1 MUTANT WITHOUT LYSOZYME FUSION
442, 4ib4A, 0.6589, 4.53, 0.107, 375, 215, CRYSTAL STRUCTURE OF THE CHIMERIC PROTEIN OF 5-HT2B-BRIL IN COMPLEX WITH ERGOTAMINE
443, 5o9hA, 0.6588, 4.37, 0.103, 294, 214, CRYSTAL STRUCTURE OF THERMOSTABILISED HUMAN C5A ANAPHYLATOXIN CHEMOTACTIC RECEPTOR 1 (C5AR) IN COMPLEX WITH NDT9513727
444, 4xt3A, 0.6588, 4.22, 0.067, 288, 210, STRUCTURE OF A VIRAL GPCR BOUND TO HUMAN CHEMOKINE CX3CL1
445, 2i37C, 0.6587, 4.37, 0.098, 318, 214, CRYSTAL STRUCTURE OF A PHOTOACTIVATED RHODOPSIN
446, 5unfA, 0.6586, 4.45, 0.062, 386, 211, XFEL STRUCTURE OF HUMAN ANGIOTENSIN II TYPE 2 RECEPTOR (MONOCLINIC FORM) IN COMPLEX WITH COMPOUND 1 (N-BENZYL-N-(2-ETHYL-4-OXO-3-{[2 - (2H-TETRAZOL-5-YL)[11 -BIPHENYL]-4-YL])
447, 5uiwA, 0.6585, 4.50, 0.074, 352, 216, CRYSTAL STRUCTURE OF CC CHEMOKINE RECEPTOR 5 (CCR5) IN COMPLEX WITH HIGH POTENCY HIV ENTRY INHIBITOR 5P7-CCL5
448, 6fk7A, 0.6576, 4.43, 0.103, 326, 214, CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS06
449, 4zjcA, 0.6575, 4.33, 0.114, 503, 211, STRUCTURES OF THE HUMAN OX1 OREXIN RECEPTOR BOUND TO SELECTIVE AND DUAL ANTAGONISTS
450, 4xnvA, 0.6572, 4.53, 0.074, 340, 216, THE HUMAN P2Y1 RECEPTOR IN COMPLEX WITH BPTU
451, 5wb2A, 0.6571, 4.26, 0.077, 419, 209, US28 BOUND TO ENGINEERED CHEMOKINE CX3CL1.35 AND NANOBODIES 
452, 4mqtA, 0.6571, 4.52, 0.126, 275, 214, STRUCTURE OF ACTIVE HUMAN M2 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO THE AGONIST IPEROXO AND ALLOSTERIC MODULATOR LY2119620
453, 5zbhA, 0.6569, 4.40, 0.080, 461, 213, THE CRYSTAL STRUCTURE OF HUMAN NEUROPEPTIDE Y Y1 RECEPTOR WITH BMS- 193885 
454, 5wb1A, 0.6569, 4.27, 0.085, 420, 212, LIGAND-FREE US28 WITH STABILIZING INTRACELLULAR NANOBODY 
455, 5g53B, 0.6568, 4.63, 0.099, 284, 212, STRUCTURE OF THE ADENOSINE A2A RECEPTOR BOUND TO AN ENGINEERED G PROTEIN
456, 5zkqB, 0.6563, 4.18, 0.092, 399, 207, CRYSTAL STRUCTURE OF THE HUMAN PLATELET-ACTIVATING FACTOR RECEPTOR IN COMPLEX WITH ABT-491 
457, 4nc3A, 0.6563, 4.54, 0.107, 370, 215, CRYSTAL STRUCTURE OF THE 5-HT2B RECEPTOR SOLVED USING SERIAL FEMTOSECOND CRYSTALLOGRAPHY IN LIPIDIC CUBIC PHASE.
458, 5v56A, 0.6557, 4.64, 0.088, 632, 216, 2.9A XFEL STRUCTURE OF THE MULTI-DOMAIN HUMAN SMOOTHENED RECEPTOR (WITH E194M MUTATION) IN COMPLEX WITH TC114
459, 4z35A, 0.6552, 4.15, 0.074, 382, 203, CRYSTAL STRUCTURE OF HUMAN LYSOPHOSPHATIDIC ACID RECEPTOR 1 IN COMPLEX WITH ONO-9910539
460, 4xeeA, 0.6552, 4.50, 0.147, 464, 217, STRUCTURE OF ACTIVE-LIKE NEUROTENSIN RECEPTOR
461, 5wqcA, 0.6549, 3.97, 0.049, 499, 205, CRYSTAL STRUCTURE OF HUMAN OREXIN 2 RECEPTOR BOUND TO THE SELECTIVE ANTAGONIST EMPA DETERMINED BY THE SYNCHROTRON LIGHT SOURCE AT SPRING- 8.
462, 6fkcA, 0.6548, 4.46, 0.090, 326, 212, CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS15
463, 4xesA, 0.6545, 4.27, 0.099, 471, 212, STRUCTURE OF ACTIVE-LIKE NEUROTENSIN RECEPTOR
464, 5v57A, 0.6543, 4.62, 0.088, 645, 216, 3.0A SYN STRUCTURE OF THE MULTI-DOMAIN HUMAN SMOOTHENED RECEPTOR IN COMPLEX WITH TC114
465, 5u09A, 0.6542, 4.47, 0.083, 478, 217, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN CB1 CANNABINOID RECEPTOR
466, 5v57B, 0.6541, 4.59, 0.084, 641, 215, 3.0A SYN STRUCTURE OF THE MULTI-DOMAIN HUMAN SMOOTHENED RECEPTOR IN COMPLEX WITH TC114
467, 5v56B, 0.6541, 4.50, 0.080, 634, 213, 2.9A XFEL STRUCTURE OF THE MULTI-DOMAIN HUMAN SMOOTHENED RECEPTOR (WITH E194M MUTATION) IN COMPLEX WITH TC114
468, 4rwdB, 0.6540, 4.58, 0.093, 400, 215, XFEL STRUCTURE OF THE HUMAN DELTA OPIOID RECEPTOR IN COMPLEX WITH A BIFUNCTIONAL PEPTIDE
469, 4z36A, 0.6538, 4.17, 0.074, 382, 203, CRYSTAL STRUCTURE OF HUMAN LYSOPHOSPHATIDIC ACID RECEPTOR 1 IN COMPLEX WITH ONO-3080573
470, 4rwdA, 0.6538, 4.59, 0.093, 401, 215, XFEL STRUCTURE OF THE HUMAN DELTA OPIOID RECEPTOR IN COMPLEX WITH A BIFUNCTIONAL PEPTIDE
471, 5g53A, 0.6537, 4.66, 0.100, 283, 211, STRUCTURE OF THE ADENOSINE A2A RECEPTOR BOUND TO AN ENGINEERED G PROTEIN
472, 4xnwC, 0.6537, 4.34, 0.071, 350, 212, THE HUMAN P2Y1 RECEPTOR IN COMPLEX WITH MRS2500
473, 5vblB, 0.6536, 4.49, 0.107, 353, 215, STRUCTURE OF APELIN RECEPTOR IN COMPLEX WITH AGONIST PEPTIDE
474, 5wiuA, 0.6531, 4.35, 0.110, 373, 210, STRUCTURE OF THE HUMAN D4 DOPAMINE RECEPTOR IN COMPLEX WITH NEMONAPRIDE
475, 4xt1A, 0.6530, 4.23, 0.077, 291, 209, STRUCTURE OF A NANOBODY-BOUND VIRAL GPCR BOUND TO HUMAN CHEMOKINE CX3CL1
476, 4xnwA, 0.6529, 4.34, 0.070, 346, 213, THE HUMAN P2Y1 RECEPTOR IN COMPLEX WITH MRS2500
477, 4mqsA, 0.6529, 4.50, 0.114, 277, 210, STRUCTURE OF ACTIVE HUMAN M2 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO THE AGONIST IPEROXO
478, 4qinA, 0.6528, 4.48, 0.093, 447, 215, STRUCTURE OF THE HUMAN SMOOTHENED RECEPTOR IN COMPLEX WITH SAG1.5
479, 4grvA, 0.6527, 4.75, 0.124, 454, 218, THE CRYSTAL STRUCTURE OF THE NEUROTENSIN RECEPTOR NTS1 IN COMPLEX WITH NEUROTENSIN (8-13)
480, 4zudA, 0.6525, 4.02, 0.044, 376, 204, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN RECEPTOR IN COMPLEX WITH INVERSE AGONIST OLMESARTAN AT 2.8A RESOLUTION.
481, 5l7iB, 0.6524, 4.49, 0.075, 572, 213, STRUCTURE OF HUMAN SMOOTHENED IN COMPLEX WITH VISMODEGIB
482, 4o9rA, 0.6518, 4.34, 0.090, 441, 211, HUMAN SMOOTHENED RECEPTOR STRUCTURE IN COMPLEX WITH CYCLOPAMINE
483, 5wivA, 0.6512, 4.53, 0.085, 379, 212, STRUCTURE OF THE SODIUM-BOUND HUMAN D4 DOPAMINE RECEPTOR IN COMPLEX WITH NEMONAPRIDE
484, 5l7dB, 0.6511, 4.55, 0.070, 578, 213, STRUCTURE OF HUMAN SMOOTHENED IN COMPLEX WITH CHOLESTEROL
485, 4mbsB, 0.6510, 4.53, 0.070, 346, 215, CRYSTAL STRUCTURE OF THE CCR5 CHEMOKINE RECEPTOR
486, 5l7dA, 0.6504, 4.39, 0.089, 588, 213, STRUCTURE OF HUMAN SMOOTHENED IN COMPLEX WITH CHOLESTEROL
487, 4rwaA, 0.6504, 4.63, 0.093, 391, 214, SYNCHROTRON STRUCTURE OF THE HUMAN DELTA OPIOID RECEPTOR IN COMPLEX WITH A BIFUNCTIONAL PEPTIDE (PSI COMMUNITY TARGET)
488, 4rwaB, 0.6501, 4.62, 0.084, 389, 214, SYNCHROTRON STRUCTURE OF THE HUMAN DELTA OPIOID RECEPTOR IN COMPLEX WITH A BIFUNCTIONAL PEPTIDE (PSI COMMUNITY TARGET)
489, 4jkvB, 0.6494, 4.35, 0.090, 450, 211, STRUCTURE OF THE HUMAN SMOOTHENED 7TM RECEPTOR IN COMPLEX WITH AN ANTITUMOR AGENT
490, 3uzcA, 0.6494, 4.52, 0.100, 291, 211, THERMOSTABILISED ADENOSINE A2A RECEPTOR IN COMPLEX WITH 4-(3-AMINO-5- PHENYL-124-TRIAZIN-6-YL)-2-CHLOROPHENOL
491, 3emlA, 0.6485, 4.52, 0.105, 448, 210, THE 2.6 A CRYSTAL STRUCTURE OF A HUMAN A2A ADENOSINE RECEPTOR BOUND TO ZM241385.
492, 4n6hA, 0.6483, 4.62, 0.079, 408, 214, 1.8 A STRUCTURE OF THE HUMAN DELTA OPIOID 7TM RECEPTOR (PSI COMMUNITY TARGET)
493, 6ddeR, 0.6482, 4.36, 0.072, 281, 209, MU OPIOID RECEPTOR-GI PROTEIN COMPLEX 
494, 3reyA, 0.6475, 4.55, 0.109, 291, 211, THERMOSTABILISED ADENOSINE A2A RECEPTOR IN COMPLEX WITH XAC
495, 4yayA, 0.6472, 4.10, 0.049, 393, 205, XFEL STRUCTURE OF HUMAN ANGIOTENSIN RECEPTOR
496, 1gzmB, 0.6469, 4.78, 0.046, 328, 216, STRUCTURE OF BOVINE RHODOPSIN IN A TRIGONAL CRYSTAL FORM
497, 5lweB, 0.6464, 4.33, 0.077, 285, 207, CRYSTAL STRUCTURE OF THE HUMAN CC CHEMOKINE RECEPTOR TYPE 9 (CCR9) IN COMPLEX WITH VERCIRNON
498, 3pwhA, 0.6464, 4.54, 0.109, 291, 211, THERMOSTABILISED ADENOSINE A2A RECEPTOR
499, 5dsgB, 0.6459, 4.66, 0.114, 399, 211, STRUCTURE OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR (M4-MT4L) BOUND TO TIOTROPIUM
500, 2pedA, 0.6459, 4.69, 0.056, 348, 215, CRYSTALLOGRAPHIC MODEL OF 9-CIS-RHODOPSIN
501, 3rzeA, 0.6454, 4.41, 0.073, 428, 206, STRUCTURE OF THE HUMAN HISTAMINE H1 RECEPTOR IN COMPLEX WITH DOXEPIN
502, 3uzaA, 0.6452, 4.51, 0.110, 291, 210, THERMOSTABILISED ADENOSINE A2A RECEPTOR IN COMPLEX WITH 6-(26- DIMETHYLPYRIDIN-4-YL)-5-PHENYL-124-TRIAZIN-3-AMINE
503, 3vgaA, 0.6451, 4.55, 0.104, 296, 211, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION
504, 3oaxB, 0.6450, 4.73, 0.056, 348, 216, CRYSTAL STRUCTURE OF BOVINE RHODOPSIN WITH BETA-IONONE
505, 1u19B, 0.6449, 4.71, 0.056, 348, 215, CRYSTAL STRUCTURE OF BOVINE RHODOPSIN AT 2.2 ANGSTROMS RESOLUTION
506, 6bqhA, 0.6447, 4.55, 0.100, 351, 211, CRYSTAL STRUCTURE OF 5-HT2C IN COMPLEX WITH RITANSERIN
507, 3rfmA, 0.6446, 4.54, 0.090, 291, 211, THERMOSTABILISED ADENOSINE A2A RECEPTOR IN COMPLEX WITH CAFFEINE
508, 4u14A, 0.6442, 4.58, 0.106, 436, 208, STRUCTURE OF THE M3 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO THE ANTAGONIST TIOTROPIUM CRYSTALLIZED WITH DISULFIDE-STABILIZED T4 LYSOZYME (DST4L)
509, 6ddfR, 0.6439, 4.44, 0.082, 281, 208, MU OPIOID RECEPTOR-GI PROTEIN COMPLEX 
510, 4mbsA, 0.6439, 4.42, 0.086, 346, 210, CRYSTAL STRUCTURE OF THE CCR5 CHEMOKINE RECEPTOR
511, 5zbqA, 0.6437, 4.51, 0.066, 463, 212, THE CRYSTAL STRUCTURE OF HUMAN NEUROPEPTIDE Y Y1 RECEPTOR WITH UR- MK299 
512, 5ndzA, 0.6433, 4.37, 0.075, 556, 212, CRYSTAL STRUCTURE OF A THERMOSTABILISED HUMAN PROTEASE-ACTIVATED RECEPTOR-2 (PAR2) IN COMPLEX WITH AZ3451 AT 3.6 ANGSTROM RESOLUTION
513, 3vg9A, 0.6429, 4.51, 0.087, 297, 207, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION
514, 2hpyA, 0.6429, 4.77, 0.056, 348, 216, CRYSTALLOGRAPHIC MODEL OF LUMIRHODOPSIN
515, 5unhB, 0.6428, 4.46, 0.067, 372, 210, SYNCHROTRON STRUCTURE OF HUMAN ANGIOTENSIN II TYPE 2 RECEPTOR IN COMPLEX WITH COMPOUND 2 (N-[(FURAN-2-YL)METHYL]-N-(4-OXO-2-PROPYL-3- {[2 -(2H-TETRAZOL-5-YL)[11 - BIPHENYL]-4-YL]METHYL}-34- DIHYDROQUINAZOLIN-6-YL)BENZAMIDE)
516, 5nddA, 0.6422, 4.39, 0.075, 567, 212, CRYSTAL STRUCTURE OF A THERMOSTABILISED HUMAN PROTEASE-ACTIVATED RECEPTOR-2 (PAR2) IN COMPLEX WITH AZ8838 AT 2.8 ANGSTROM RESOLUTION
517, 5nj6A, 0.6420, 4.39, 0.075, 401, 212, CRYSTAL STRUCTURE OF A THERMOSTABILISED HUMAN PROTEASE-ACTIVATED RECEPTOR-2 (PAR2) IN TERNARY COMPLEX WITH FAB3949 AND AZ7188 AT 4.0 ANGSTROM RESOLUTION
518, 5uigA, 0.6413, 4.67, 0.095, 387, 211, CRYSTAL STRUCTURE OF ADENOSINE A2A RECEPTOR BOUND TO A NOVEL TRIAZOLE- CARBOXIMIDAMIDE ANTAGONIST
519, 5xjmA, 0.6412, 4.49, 0.038, 375, 209, COMPLEX STRUCTURE OF ANGIOTENSIN II TYPE 2 RECEPTOR WITH FAB 
520, 1f88A, 0.6412, 4.76, 0.047, 338, 215, CRYSTAL STRUCTURE OF BOVINE RHODOPSIN
521, 5lweA, 0.6404, 4.34, 0.058, 275, 208, CRYSTAL STRUCTURE OF THE HUMAN CC CHEMOKINE RECEPTOR TYPE 9 (CCR9) IN COMPLEX WITH VERCIRNON
522, 2j4yA, 0.6396, 4.81, 0.051, 326, 217, CRYSTAL STRUCTURE OF A RHODOPSIN STABILIZING MUTANT EXPRESSED IN MAMMALIAN CELLS
523, 2j4yB, 0.6394, 4.81, 0.051, 326, 217, CRYSTAL STRUCTURE OF A RHODOPSIN STABILIZING MUTANT EXPRESSED IN MAMMALIAN CELLS
524, 5xf1A, 0.6391, 4.59, 0.081, 544, 209, STRUCTURE OF THE FULL-LENGTH GLUCAGON CLASS B G PROTEIN-COUPLED RECEPTOR
525, 5xezB, 0.6389, 4.53, 0.082, 499, 208, STRUCTURE OF THE FULL-LENGTH GLUCAGON CLASS B G PROTEIN-COUPLED RECEPTOR
526, 5xezA, 0.6389, 4.62, 0.081, 545, 210, STRUCTURE OF THE FULL-LENGTH GLUCAGON CLASS B G PROTEIN-COUPLED RECEPTOR
527, 6bqgA, 0.6387, 4.82, 0.085, 378, 213, CRYSTAL STRUCTURE OF 5-HT2C IN COMPLEX WITH ERGOTAMINE
528, 5xr8A, 0.6383, 4.80, 0.102, 431, 216, CRYSTAL STRUCTURE OF THE HUMAN CB1 IN COMPLEX WITH AGONIST AM841
529, 4z34A, 0.6382, 4.70, 0.096, 385, 209, CRYSTAL STRUCTURE OF HUMAN LYSOPHOSPHATIDIC ACID RECEPTOR 1 IN COMPLEX WITH ONO9780307
530, 4dajC, 0.6379, 4.76, 0.110, 430, 209, STRUCTURE OF THE M3 MUSCARINIC ACETYLCHOLINE RECEPTOR
531, 5xf1B, 0.6371, 4.60, 0.086, 496, 209, STRUCTURE OF THE FULL-LENGTH GLUCAGON CLASS B G PROTEIN-COUPLED RECEPTOR
532, 1ln6A, 0.6367, 4.25, 0.062, 309, 208, STRUCTURE OF BOVINE RHODOPSIN (METARHODOPSIN II)
533, 4py0A, 0.6365, 4.43, 0.098, 389, 214, CRYSTAL STRUCTURE OF P2Y12 RECEPTOR IN COMPLEX WITH 2MESATP
534, 5v54B, 0.6361, 4.61, 0.086, 383, 210, CRYSTAL STRUCTURE OF 5-HT1B RECEPTOR IN COMPLEX WITH METHIOTHEPIN
535, 4jkvA, 0.6356, 4.47, 0.062, 454, 209, STRUCTURE OF THE HUMAN SMOOTHENED 7TM RECEPTOR IN COMPLEX WITH AN ANTITUMOR AGENT
536, 5cxvA, 0.6347, 4.76, 0.110, 444, 210, STRUCTURE OF THE HUMAN M1 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO ANTAGONIST TIOTROPIUM
537, 5x33A, 0.6345, 4.48, 0.091, 439, 208, LEUKOTRIENE B4 RECEPTOR BLT1 IN COMPLEX WITH BIIL260
538, 5te5A, 0.6344, 4.84, 0.069, 348, 217, CRYSTAL STRUCTURE OF BOS TAURUS OPSIN REGENERATED WITH 6-CARBON RING RETINAL CHROMOPHORE
539, 5xprA, 0.6342, 4.52, 0.058, 411, 207, HUMAN ENDOTHELIN RECEPTOR TYPE-B IN COMPLEX WITH ANTAGONIST BOSENTAN
540, 5x93A, 0.6337, 4.68, 0.052, 430, 210, HUMAN ENDOTHELIN RECEPTOR TYPE-B IN COMPLEX WITH ANTAGONIST K-8794
541, 4dajB, 0.6337, 4.78, 0.110, 430, 209, STRUCTURE OF THE M3 MUSCARINIC ACETYLCHOLINE RECEPTOR
542, 5xraA, 0.6330, 4.45, 0.066, 428, 213, CRYSTAL STRUCTURE OF THE HUMAN CB1 IN COMPLEX WITH AGONIST AM11542
543, 5kw2A, 0.6323, 4.35, 0.121, 411, 206, THE EXTRA-HELICAL BINDING SITE OF GPR40 AND THE STRUCTURAL BASIS FOR ALLOSTERIC AGONISM AND INCRETIN STIMULATION 
544, 5tvnA, 0.6320, 4.59, 0.096, 393, 209, CRYSTAL STRUCTURE OF THE LSD-BOUND 5-HT2B RECEPTOR
545, 3uonA, 0.6320, 4.89, 0.114, 438, 211, STRUCTURE OF THE HUMAN M2 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO AN ANTAGONIST
546, 5t04A, 0.6307, 4.65, 0.143, 458, 217, STRUCTURE OF CONSTITUTIVELY ACTIVE NEUROTENSIN RECEPTOR
547, 6b73A, 0.6300, 4.56, 0.096, 281, 208, CRYSTAL STRUCTURE OF A NANOBODY-STABILIZED ACTIVE STATE OF THE KAPPA- OPIOID RECEPTOR
548, 6cm4A, 0.6298, 4.72, 0.090, 423, 212, STRUCTURE OF THE D2 DOPAMINE RECEPTOR BOUND TO THE ATYPICAL ANTIPSYCHOTIC DRUG RISPERIDONE
549, 5v54A, 0.6291, 4.66, 0.095, 382, 211, CRYSTAL STRUCTURE OF 5-HT1B RECEPTOR IN COMPLEX WITH METHIOTHEPIN
550, 4u15B, 0.6291, 4.35, 0.080, 392, 200, M3-MT4L RECEPTOR BOUND TO TIOTROPIUM
551, 6fkbA, 0.6286, 4.67, 0.062, 328, 210, CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS13
552, 5tudD, 0.6281, 4.64, 0.067, 371, 209, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
553, 6fk8A, 0.6278, 4.83, 0.061, 326, 212, CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS08
554, 4u16B, 0.6276, 4.46, 0.080, 392, 201, M3-MT4L RECEPTOR BOUND TO NMS
555, 4dajA, 0.6275, 4.77, 0.101, 429, 208, STRUCTURE OF THE M3 MUSCARINIC ACETYLCHOLINE RECEPTOR
556, 5c1mA, 0.6271, 4.58, 0.076, 295, 210, CRYSTAL STRUCTURE OF ACTIVE MU-OPIOID RECEPTOR BOUND TO THE AGONIST BU72
557, 4buoA, 0.6270, 4.46, 0.073, 304, 205, HIGH RESOLUTION STRUCTURE OF THERMOSTABLE AGONIST-BOUND NEUROTENSIN RECEPTOR 1 MUTANT WITHOUT LYSOZYME FUSION
558, 6fkaA, 0.6265, 4.66, 0.062, 326, 210, CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS11
559, 4u16A, 0.6258, 4.44, 0.085, 381, 199, M3-MT4L RECEPTOR BOUND TO NMS
560, 5tudA, 0.6257, 4.67, 0.067, 373, 209, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
561, 6fkdA, 0.6256, 4.74, 0.071, 326, 211, CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS16
562, 4dajD, 0.6255, 4.48, 0.084, 432, 202, STRUCTURE OF THE M3 MUSCARINIC ACETYLCHOLINE RECEPTOR
563, 4iaqA, 0.6253, 4.65, 0.072, 367, 209, CRYSTAL STRUCTURE OF THE CHIMERIC PROTEIN OF 5-HT1B-BRIL IN COMPLEX WITH DIHYDROERGOTAMINE (PSI COMMUNITY TARGET)
564, 6fk6A, 0.6250, 4.71, 0.062, 326, 209, CRYSTAL STRUCTURE OF N2C/D282C STABILIZED OPSIN BOUND TO RS01
565, 5zkpA, 0.6240, 4.86, 0.085, 436, 211, CRYSTAL STRUCTURE OF THE HUMAN PLATELET-ACTIVATING FACTOR RECEPTOR IN COMPLEX WITH SR 27417 
566, 5tgzA, 0.6223, 4.89, 0.103, 439, 214, CRYSTAL STRUCTURE OF THE HUMAN CANNABINOID RECEPTOR CB1
567, 5gliA, 0.6221, 4.63, 0.058, 429, 207, HUMAN ENDOTHELIN RECEPTOR TYPE-B IN THE LIGAND-FREE FORM
568, 5dsgA, 0.6214, 4.60, 0.093, 392, 204, STRUCTURE OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR (M4-MT4L) BOUND TO TIOTROPIUM
569, 4zj8A, 0.6207, 4.50, 0.078, 503, 204, STRUCTURES OF THE HUMAN OX1 OREXIN RECEPTOR BOUND TO SELECTIVE AND DUAL ANTAGONISTS
570, 4z9gB, 0.6200, 4.64, 0.112, 415, 205, CRYSTAL STRUCTURE OF HUMAN CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRF1R) IN COMPLEX WITH THE ANTAGONIST CP-376395 IN A HEXAGONAL SETTING WITH TRANSLATIONAL NON-CRYSTALLOGRAPHIC SYMMETRY
571, 4z9gA, 0.6196, 4.77, 0.096, 421, 208, CRYSTAL STRUCTURE OF HUMAN CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRF1R) IN COMPLEX WITH THE ANTAGONIST CP-376395 IN A HEXAGONAL SETTING WITH TRANSLATIONAL NON-CRYSTALLOGRAPHIC SYMMETRY
572, 5vewA, 0.6189, 4.59, 0.078, 422, 205, STRUCTURE OF THE HUMAN GLP-1 RECEPTOR COMPLEX WITH PF-06372222
573, 5vewB, 0.6178, 4.48, 0.079, 423, 203, STRUCTURE OF THE HUMAN GLP-1 RECEPTOR COMPLEX WITH PF-06372222
574, 4u15A, 0.6174, 4.54, 0.045, 391, 201, M3-MT4L RECEPTOR BOUND TO TIOTROPIUM
575, 5vexA, 0.6171, 4.59, 0.074, 422, 204, STRUCTURE OF THE HUMAN GLP-1 RECEPTOR COMPLEX WITH NNC0640
576, 5dhhB, 0.6163, 4.48, 0.100, 387, 201, THE CRYSTAL STRUCTURE OF NOCICEPTIN/ORPHANIN FQ PEPTIDE RECEPTOR (NOP) IN COMPLEX WITH SB-612111 (PSI COMMUNITY TARGET)
577, 5vexB, 0.6161, 4.57, 0.078, 422, 204, STRUCTURE OF THE HUMAN GLP-1 RECEPTOR COMPLEX WITH NNC0640
578, 6b73B, 0.6153, 4.59, 0.088, 269, 204, CRYSTAL STRUCTURE OF A NANOBODY-STABILIZED ACTIVE STATE OF THE KAPPA- OPIOID RECEPTOR
579, 4or2B, 0.6143, 4.72, 0.080, 366, 212, HUMAN CLASS C G PROTEIN-COUPLED METABOTROPIC GLUTAMATE RECEPTOR 1 IN COMPLEX WITH A NEGATIVE ALLOSTERIC MODULATOR
580, 5ee7A, 0.6119, 4.59, 0.118, 416, 203, CRYSTAL STRUCTURE OF THE HUMAN GLUCAGON RECEPTOR (GCGR) IN COMPLEX WITH THE ANTAGONIST MK-0893
581, 4or2A, 0.6098, 4.62, 0.086, 360, 209, HUMAN CLASS C G PROTEIN-COUPLED METABOTROPIC GLUTAMATE RECEPTOR 1 IN COMPLEX WITH A NEGATIVE ALLOSTERIC MODULATOR
582, 4k5yC, 0.6079, 4.80, 0.083, 248, 205, CRYSTAL STRUCTURE OF HUMAN CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRF1R) IN COMPLEX WITH THE ANTAGONIST CP-376395
583, 4k5yA, 0.6040, 4.79, 0.115, 407, 200, CRYSTAL STRUCTURE OF HUMAN CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRF1R) IN COMPLEX WITH THE ANTAGONIST CP-376395
584, 5yqzR, 0.6027, 5.03, 0.113, 558, 203, STRUCTURE OF THE GLUCAGON RECEPTOR IN COMPLEX WITH A GLUCAGON ANALOGUE
585, 3aymA, 0.6022, 4.73, 0.083, 350, 205, CRYSTAL STRUCTURE OF THE BATHO INTERMEDIATE OF SQUID RHODOPSIN
586, 3aynA, 0.6020, 4.73, 0.083, 350, 205, CRYSTAL STRUCTURE OF SQUID ISORHODOPSIN
587, 6cmoR, 0.5979, 4.99, 0.062, 323, 210, RHODOPSIN-GI COMPLEX 
588, 4k5yB, 0.5945, 4.85, 0.090, 396, 200, CRYSTAL STRUCTURE OF HUMAN CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRF1R) IN COMPLEX WITH THE ANTAGONIST CP-376395
589, 4z9gC, 0.5912, 4.73, 0.091, 403, 197, CRYSTAL STRUCTURE OF HUMAN CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1 (CRF1R) IN COMPLEX WITH THE ANTAGONIST CP-376395 IN A HEXAGONAL SETTING WITH TRANSLATIONAL NON-CRYSTALLOGRAPHIC SYMMETRY
590, 4iarA, 0.5907, 4.53, 0.103, 379, 194, CRYSTAL STRUCTURE OF THE CHIMERIC PROTEIN OF 5-HT1B-BRIL IN COMPLEX WITH ERGOTAMINE (PSI COMMUNITY TARGET)
591, 4ntjA, 0.5807, 4.96, 0.087, 369, 206, STRUCTURE OF THE HUMAN P2Y12 RECEPTOR IN COMPLEX WITH AN ANTITHROMBOTIC DRUG
592, 5uz7R, 0.5257, 5.40, 0.058, 266, 191, VOLTA PHASE PLATE CRYO-ELECTRON MICROSCOPY STRUCTURE OF A CALCITONIN RECEPTOR-HETEROTRIMERIC GS PROTEIN COMPLEX
593, 4xwjA, 0.5020, 3.31, 0.057, 153, 140, HISTIDINE-CONTAINING PHOSPHOCARRIER PROTEIN (HPR) AND ANTISIGMA FACTOR RSD COMPLEX
